1	T79OM	NN	O	t79om	nn	2	SENT_1	[p1l7t310r316b383],
2	mutation	NN	O	mutation	nsubjpass	4	SENT_1	[p1l348t305r747b384],
3	Was	VBD	O	be	auxpass	4	SENT_1	[p1l774t331r939b384],
4	shown	VBN	O	show	dep	35	SENT_1	[p1l974t305r1260b384],
5	to	TO	O	to	aux	6	SENT_1	[p1l1291t321r1372b383],
6	confer	VB	O	confer	xcomp	4	SENT_1	[p1l1405t304r1683b383],
7	resistance	NN	O	resistance	dobj	6	SENT_1	[p1l1712t305r2147b383],
8	to	TO	O	to	_	0	SENT_1	[p1l11t449r91b511],
9	geﬁtinib	NN	O	geﬁtinib	prep_to	6	SENT_1	[p1l139t432r505b533],
10	after	IN	O	after	mark	13	SENT_1	[p1l553t432r752b511],
11	it	PRP	O	it	nsubjpass	13	SENT_1	[p1l795t433r856b511],
12	Was	VBD	O	be	auxpass	13	SENT_1	[p1l894t459r1058b512],
13	introduced	VBN	O	introduce	advcl	6	SENT_1	[p1l1107t432r1581b512],
14	into	IN	O	into	_	0	SENT_1	[p1l1627t433r1796b511],
15	the	DT	O	the	det	16	SENT_1	[p1l1845t433r1978b511],
16	sequence	NN	O	sequence	prep_into	13	SENT_1	[p1l2027t459r2145b511, p1l11t586r316b661],
17	of	IN	O	of	_	0	SENT_1	[p1l354t560r456b639],
18	the	DT	O	the	det	22	SENT_1	[p1l474t561r606b639],
19	Wild	NNP	O	Wild	nn	22	SENT_1	[p1l638t560r1042b661],
20	—	CD	NUMBER	—	num	22	SENT_1	[p1l638t560r1042b661],
21	type	NN	O	type	nn	22	SENT_1	[p1l638t560r1042b661],
22	EGFR	NN	ORGANIZATION	egfr	prep_of	16	SENT_1	[p1l1077t567r1294b640],
23	and	CC	O	and	_	0	SENT_1	[p1l1322t560r1482b639],
24	L858R	NN	O	l858r	nn	26	SENT_1	[p1l1516t566r1807b644],
25	mutant	JJ	O	mutant	amod	26	SENT_1	[p1l1832t577r2151b640],
26	EGFR	NN	ORGANIZATION	egfr	prep_into	13	SENT_1	[p1l8t695r225b768],
27	in	FW	O	in	nn	28	SENT_1	[p1l257t689r341b766],
28	vitro	FW	O	vitro	advmod	29	SENT_1	[p1l376t689r709b768],
29	.2	NN	NUMBER	.2	rcmod	26	SENT_1	[p1l376t689r709b768],
30	>	JJR	O	>	dep	29	SENT_1	[p1l376t689r709b768],
31	3	CD	NUMBER	3	dep	30	SENT_1	[p1l376t689r709b768],
32	The	DT	O	the	det	34	SENT_1	[p1l747t689r912b767],
33	T79OM	NN	O	t79om	nn	34	SENT_1	[p1l948t694r1257b767],
34	mutation	NN	O	mutation	nsubj	35	SENT_1	[p1l1299t689r1698b768],
35	results	VBZ	O	result	_	0	SENT_1	[p1l1737t688r2022b768],
36	in	IN	O	in	_	0	SENT_1	[p1l2063t689r2147b766],
37	steric	JJ	O	steric	amod	38	SENT_1	[p1l12t817r238b895],
38	hindrance	NN	O	hindrance	prep_in	35	SENT_1	[p1l263t816r691b895],
39	of	IN	O	of	_	0	SENT_1	[p1l719t816r820b895],
40	binding	NN	O	binding	prep_of	38	SENT_1	[p1l828t817r1164b917],
41	of	IN	O	of	_	0	SENT_1	[p1l1187t816r1288b895],
42	gefitinib	NN	O	gefitinib	prep_of	40	SENT_1	[p1l1295t816r1652b917],
43	to	TO	O	to	_	0	SENT_1	[p1l1680t833r1760b895],
44	the	DT	O	the	det	48	SENT_1	[p1l1788t816r1918b895],
45	ATPkinase	NN	O	atpkinase	nn	48	SENT_1	[p1l1940t822r2147b894, p1l10t944r690b1045],
46	—	NN	O	—	nn	48	SENT_1	[p1l1940t822r2147b894, p1l10t944r690b1045],
47	binding	NN	O	binding	nn	48	SENT_1	[p1l1940t822r2147b894, p1l10t944r690b1045],
48	pocket	NN	O	pocket	prep_to	35	SENT_1	[p1l753t945r1068b1045],
49	.	.	O	.	_	0	SENT_1	[p1l753t945r1068b1045],

1	The	DT	O	the	det	3	SENT_2	[p1l1139t945r1303b1023],
2	T79OM	NN	O	t79om	nn	3	SENT_2	[p1l1368t950r1678b1023],
3	mutation	NN	O	mutation	nsubj	5	SENT_2	[p1l1748t945r2147b1024],
4	may	MD	O	may	aux	5	SENT_2	[p1l10t1099r190b1173],
5	cause	VB	O	cause	_	0	SENT_2	[p1l213t1099r450b1152],
6	acquired	VBN	O	acquire	amod	7	SENT_2	[p1l477t1072r851b1173],
7	resistance	NN	O	resistance	dobj	5	SENT_2	[p1l878t1073r1313b1151],
8	to	TO	O	to	_	0	SENT_2	[p1l1341t1089r1422b1151],
9	geﬁtinib	NN	O	geﬁtinib	nn	10	SENT_2	[p1l1450t1072r1952b1173],
10	.2	NN	NUMBER	.2	prep_to	5	SENT_2	[p1l1450t1072r1952b1173],
11	»	CD	NUMBER	»	number	12	SENT_2	[p1l1450t1072r1952b1173],
12	3	CD	NUMBER	3	num	10	SENT_2	[p1l1450t1072r1952b1173],
13	Our	PRP$	O	we	poss	14	SENT_2	[p1l1982t1078r2149b1152],
14	patient	NN	O	patient	nsubj	30	SENT_2	[p1l8t1201r306b1301],
15	had	VBD	O	have	dep	5	SENT_2	[p1l337t1201r492b1279],
16	concomitant	JJ	O	concomitant	amod	17	SENT_2	[p1l530t1201r1068b1279],
17	T79OM	NN	O	t79om	dobj	15	SENT_2	[p1l1096t1206r1399b1279],
18	and	CC	O	and	_	0	SENT_2	[p1l1436t1201r1592b1279],
19	L858R	NN	O	l858r	nn	21	SENT_2	[p1l1627t1206r1912b1284],
20	EGFR	NN	ORGANIZATION	egfr	nn	21	SENT_2	[p1l1935t1207r2153b1280],
21	mutations	NNS	O	mutation	conj_and	17	SENT_2	[p1l10t1329r451b1408],
22	in	IN	O	in	_	0	SENT_2	[p1l495t1329r577b1406],
23	the	DT	O	the	det	28	SENT_2	[p1l620t1329r751b1407],
24	original	JJ	O	original	amod	28	SENT_2	[p1l794t1329r1133b1429],
25	lung	NN	O	lung	nn	28	SENT_2	[p1l1173t1329r1696b1429],
26	—	NN	O	—	nn	28	SENT_2	[p1l1173t1329r1696b1429],
27	biopsy	NN	O	biopsy	nn	28	SENT_2	[p1l1173t1329r1696b1429],
28	specimen	NN	O	specimen	prep_in	15	SENT_2	[p1l1734t1329r2147b1429],
29	and	CC	O	and	_	0	SENT_2	[p1l9t1457r168b1535],
30	showed	VBD	O	show	dep	5	SENT_2	[p1l211t1456r541b1536],
31	primary	JJ	O	primary	amod	32	SENT_2	[p1l580t1457r925b1557],
32	resistance	NN	O	resistance	dobj	30	SENT_2	[p1l961t1457r1396b1535],
33	to	TO	O	to	aux	34	SENT_2	[p1l1437t1473r1518b1535],
34	geﬁtinib	VB	O	geﬁtinib	xcomp	30	SENT_2	[p1l1559t1456r1925b1557],
35	—	CD	NUMBER	—	dobj	34	SENT_2	[p1l1963t1501r2071b1509],
36	a	DT	O	a	det	37	SENT_2	[p1l2105t1483r2149b1535],
37	ﬁnding	NN	O	ﬁnding	dobj	15	SENT_2	[p1l10t1584r324b1685],
38	implying	VBG	O	imply	partmod	37	SENT_2	[p1l347t1585r730b1685],
39	that	IN	O	that	complm	48	SENT_2	[p1l755t1585r922b1663],
40	a	DT	O	a	det	41	SENT_2	[p1l944t1611r989b1663],
41	mutation	NN	O	mutation	nsubj	48	SENT_2	[p1l1015t1585r1407b1664],
42	in	IN	O	in	_	0	SENT_2	[p1l1434t1585r1516b1662],
43	the	DT	O	the	det	46	SENT_2	[p1l1544t1585r1673b1663],
44	T79OM	NN	O	t79om	nn	46	SENT_2	[p1l1698t1590r2003b1663],
45	kinase	NN	O	kinase	nn	46	SENT_2	[p1l2033t1585r2145b1664, p1l10t1738r203b1791],
46	domain	NN	O	domain	prep_in	41	SENT_2	[p1l238t1712r569b1791],
47	can	MD	O	can	aux	48	SENT_2	[p1l603t1738r750b1791],
48	occur	VB	O	occur	ccomp	38	SENT_2	[p1l785t1738r1024b1792],
49	during	IN	O	during	_	0	SENT_2	[p1l1056t1713r1347b1813],
50	the	DT	O	the	det	52	SENT_2	[p1l1378t1713r1510b1791],
51	natural	JJ	O	natural	amod	52	SENT_2	[p1l1544t1713r1851b1792],
52	evolution	NN	O	evolution	prep_during	48	SENT_2	[p1l1885t1713r2145b1792, p1l11t1841r180b1919],
53	of	IN	O	of	_	0	SENT_2	[p1l241t1840r343b1919],
54	lung	NN	O	lung	nn	55	SENT_2	[p1l383t1841r581b1941],
55	cancer	NN	O	cancer	prep_of	52	SENT_2	[p1l638t1866r938b1919],
56	.	.	O	.	_	0	SENT_2	[p1l638t1866r938b1919],

1	T79OM	NN	O	t79om	_	0	SENT_3	[p1l1000t1846r1309b1919],
2	mutant	JJ	O	mutant	amod	4	SENT_3	[p1l1370t1857r1690b1920],
3	gefitinib	NN	O	gefitinib	nn	4	SENT_3	[p1l1744t1840r2145b1941],
4	—	NN	O	—	dep	1	SENT_3	[p1l1744t1840r2145b1941],
5	resistant	JJ	O	resistant	dep	1	SENT_3	[p1l10t1969r389b2047],
6	clones	NNS	O	clone	nsubj	8	SENT_3	[p1l423t1969r697b2047],
7	may	MD	O	may	aux	8	SENT_3	[p1l738t1995r917b2069],
8	preexist	VB	O	preexist	ccomp	5	SENT_3	[p1l950t1969r1296b2069],
9	at	IN	O	at	_	0	SENT_3	[p1l1329t1985r1409b2047],
10	levels	NNS	O	level	prep_at	8	SENT_3	[p1l1442t1968r1677b2048],
11	below	IN	O	below	_	0	SENT_3	[p1l1718t1968r1979b2048],
12	the	DT	O	the	det	13	SENT_3	[p1l2014t1968r2147b2047],
13	threshold	NN	O	threshold	prep_below	8	SENT_3	[p1l11t2096r427b2175],
14	of	IN	O	of	_	0	SENT_3	[p1l457t2096r558b2175],
15	detection5	NN	O	detection5	prep_of	13	SENT_3	[p1l568t2096r991b2175],
16	in	IN	O	in	_	0	SENT_3	[p1l1022t2097r1103b2174],
17	some	DT	O	some	det	18	SENT_3	[p1l1133t2122r1357b2175],
18	patients	NNS	O	patient	prep_in	15	SENT_3	[p1l1384t2097r1717b2197],
19	with	IN	O	with	_	0	SENT_3	[p1l1743t2097r1931b2176],
20	lung	NN	O	lung	nn	21	SENT_3	[p1l1958t2096r2152b2197],
21	cancer	NN	O	cancer	prep_with	8	SENT_3	[p1l11t2250r293b2303],
22	at	IN	O	at	_	0	SENT_3	[p1l329t2241r409b2303],
23	presentation	NN	O	presentation	prep_at	21	SENT_3	[p1l442t2225r992b2325],
24	and	CC	O	and	_	0	SENT_3	[p1l1031t2225r1190b2303],
25	then	RB	O	then	advmod	5	SENT_3	[p1l1229t2225r1421b2303],
26	may	MD	O	may	aux	27	SENT_3	[p1l1460t2251r1639b2325],
27	expand	VB	O	expand	dep	1	SENT_3	[p1l1675t2225r1986b2325],
28	selectively	RB	O	selectively	advmod	27	SENT_3	[p1l2026t2251r2145b2303, p1l9t2353r358b2453],
29	under	IN	O	under	_	0	SENT_3	[p1l385t2352r639b2432],
30	gefitinib	NN	O	gefitinib	nn	31	SENT_3	[p1l668t2352r1033b2453],
31	treatment	NN	O	treatment	prep_under	27	SENT_3	[p1l1067t2369r1512b2448],
32	,	,	O	,	_	0	SENT_3	[p1l1067t2369r1512b2448],
33	leading	VBG	O	lead	partmod	1	SENT_3	[p1l1548t2352r1872b2453],
34	to	TO	O	to	_	0	SENT_3	[p1l1901t2369r1981b2431],
35	the	DT	O	the	det	36	SENT_3	[p1l2014t2353r2147b2431],
36	failure	NN	O	failure	prep_to	33	SENT_3	[p1l10t2480r287b2560],
37	of	IN	O	of	_	0	SENT_3	[p1l316t2480r417b2559],
38	geﬁtinib	NN	O	geﬁtinib	nn	39	SENT_3	[p1l426t2480r792b2581],
39	therapy	NN	O	therapy	prep_of	1	SENT_3	[p1l821t2480r1159b2581],
40	.	.	O	.	_	0	SENT_3	[p1l821t2480r1159b2581],

1	Jin-Yuan	NNP	PERSON	Jin-Yuan	nn	2	SENT_4	[p1l6t2647r373b2742],
2	Shih	NNP	PERSON	Shih	_	0	SENT_4	[p1l413t2639r626b2733],
3	,	,	O	,	_	0	SENT_4	[p1l413t2639r626b2733],
4	M.D.	NNP	O	M.D.	nn	6	SENT_4	[p1l671t2647r904b2733],
5	,	,	O	,	_	0	SENT_4	[p1l671t2647r904b2733],
6	Ph.D.	NNP	O	Ph.D.	appos	2	SENT_4	[p1l949t2639r1178b2719],
7	.	.	O	.	_	0	SENT_4	[p1l949t2639r1178b2719],

1	Chien-Hung	NNP	PERSON	Chien-Hung	nn	2	SENT_5	[p1l21t2768r557b2874],
2	Gow	NNP	PERSON	Gow	_	0	SENT_5	[p1l590t2774r800b2862],
3	,	,	O	,	_	0	SENT_5	[p1l590t2774r800b2862],
4	M.D.	NNP	PERSON	M.D.	nn	6	SENT_5	[p1l845t2776r1051b2848],
5	Pan-Chyr	NNP	PERSON	Pan-Chyr	nn	6	SENT_5	[p1l28t2920r419b3026],
6	Yang	NNP	PERSON	Yang	appos	2	SENT_5	[p1l445t2928r676b3026],
7	,	,	O	,	_	0	SENT_5	[p1l445t2928r676b3026],
8	M.D.	NNP	O	M.D.	nn	10	SENT_5	[p1l721t2928r953b3014],
9	,	,	O	,	_	0	SENT_5	[p1l721t2928r953b3014],
10	Ph.D.	NNP	O	Ph.D.	appos	6	SENT_5	[p1l998t2920r1227b3000],
11	.	.	O	.	_	0	SENT_5	[p1l998t2920r1227b3000],

1	National	NNP	ORGANIZATION	National	nn	5	SENT_6	[p1l24t3061r300b3122],
2	Taiwan	NNP	ORGANIZATION	Taiwan	nn	5	SENT_6	[p1l325t3067r549b3122],
3	University	NNP	ORGANIZATION	University	nn	5	SENT_6	[p1l581t3067r909b3141],
4	Hospital	NNP	ORGANIZATION	Hospital	nn	5	SENT_6	[p1l937t3061r1210b3140],
5	Taipei	NNP	ORGANIZATION	Taipei	_	0	SENT_6	[p1l16t3163r206b3236],
6	100	CD	NUMBER	100	num	5	SENT_6	[p1l239t3161r367b3229],
7	,	,	O	,	_	0	SENT_6	[p1l239t3161r367b3229],
8	Taiwan	NNP	LOCATION	Taiwan	nn	9	SENT_6	[p1l391t3163r615b3218],
9	pcyang@ha.mc.ntu.edu.tw	NN	O	pcyang@ha.mc.ntu.edu.tw	appos	5	SENT_6	[p1l23t3253r917b3333],

1	1	LS	NUMBER	1	_	0	SENT_7	[p2l21t26r69b76],
2	.	.	O	.	_	0	SENT_7	[p2l21t26r69b76],

1	Lynch	NNP	PERSON	Lynch	nn	3	SENT_8	[p2l147t18r335b93],
2	T	NN	O	t	nn	3	SENT_8	[p2l354t23r437b90],
3	]	NN	O	]	_	0	SENT_8	[p2l354t23r437b90],
4	,	,	O	,	_	0	SENT_8	[p2l354t23r437b90],
5	Bell	NNP	ORGANIZATION	Bell	nn	6	SENT_8	[p2l461t18r581b76],
6	DW	NNP	ORGANIZATION	DW	appos	3	SENT_8	[p2l601t23r730b89],
7	,	,	O	,	_	0	SENT_8	[p2l601t23r730b89],
8	Sordella	NNP	PERSON	Sordella	nn	9	SENT_8	[p2l757t18r1012b77],
9	R	NNP	PERSON	R	appos	3	SENT_8	[p2l1031t23r1095b90],
10	,	,	O	,	_	0	SENT_8	[p2l1031t23r1095b90],
11	et	FW	O	et	nn	12	SENT_8	[p2l1122t31r1179b76],
12	al.	FW	O	al.	appos	3	SENT_8	[p2l1196t18r1266b77],
13	.	.	O	.	_	0	SENT_8	[p2l1196t18r1266b77],

1	Activating	VBG	O	activate	amod	2	SENT_9	[p2l1289t19r1610b94],
2	mutations	NNS	O	mutation	_	0	SENT_9	[p2l1628t19r1948b77],
3	in	IN	O	in	_	0	SENT_9	[p2l1971t19r2032b76],
4	the	DT	O	the	det	7	SENT_9	[p2l2053t18r2149b76],
5	epidermal	JJ	O	epidermal	amod	7	SENT_9	[p2l19t114r336b190],
6	growth	NN	O	growth	nn	7	SENT_9	[p2l351t114r577b191],
7	factor	NN	O	factor	prep_in	2	SENT_9	[p2l593t114r776b174],
8	receptor	NN	O	receptor	nn	10	SENT_9	[p2l789t127r1051b190],
9	underlying	VBG	O	underlie	amod	10	SENT_9	[p2l1064t114r1407b191],
10	responsiveness	NN	O	responsiveness	dep	2	SENT_9	[p2l1419t115r1894b190],
11	of	IN	O	of	_	0	SENT_9	[p2l1912t114r1988b174],
12	nonsmall-cell	JJ	O	nonsmall-cell	amod	14	SENT_9	[p2l1989t134r2153b174, p2l20t211r323b270],
13	lung	NN	O	lung	nn	14	SENT_9	[p2l340t211r485b288],
14	cancer	NN	O	cancer	prep_of	10	SENT_9	[p2l501t231r706b270],
15	to	TO	O	to	_	0	SENT_9	[p2l722t224r781b271],
16	geﬁtinib	NN	O	geﬁtinib	prep_to	14	SENT_9	[p2l800t211r1082b288],
17	.	.	O	.	_	0	SENT_9	[p2l800t211r1082b288],

1	N	NN	O	n	nn	3	SENT_10	[p2l1103t216r1159b271],
2	Engl	NNP	O	Engl	nn	3	SENT_10	[p2l1175t211r1358b288],
3	]	NNP	O	]	nsubj	4	SENT_10	[p2l1175t211r1358b288],
4	Med	VBD	O	med	_	0	SENT_10	[p2l1372t211r1512b271],
5	2004	CD	DATE	2004	dobj	4	SENT_10	[p2l1529t215r2125b283],
6	;	:	O	;	_	0	SENT_10	[p2l1529t215r2125b283],
7	350:2129	CD	NUMBER	350:2129	number	8	SENT_10	[p2l1529t215r2125b283],
8	—	CD	NUMBER	—	dep	5	SENT_10	[p2l1529t215r2125b283],
9	39	CD	NUMBER	39	dep	8	SENT_10	[p2l1529t215r2125b283],
10	.	.	O	.	_	0	SENT_10	[p2l1529t215r2125b283],

1	2	LS	NUMBER	2	_	0	SENT_11	[p2l17t315r70b367],
2	.	.	O	.	_	0	SENT_11	[p2l17t315r70b367],

1	Kobayashi	NNP	LOCATION	Kobayashi	nn	2	SENT_12	[p2l147t308r478b383],
2	S	NNP	LOCATION	S	_	0	SENT_12	[p2l504t312r556b380],
3	,	,	O	,	_	0	SENT_12	[p2l504t312r556b380],
4	Boggon	NNP	PERSON	Boggon	nn	6	SENT_12	[p2l584t313r834b384],
5	T	NN	O	t	nn	6	SENT_12	[p2l856t313r940b380],
6	]	NN	O	]	appos	2	SENT_12	[p2l856t313r940b380],
7	,	,	O	,	_	0	SENT_12	[p2l856t313r940b380],
8	Dayaram	NN	ORGANIZATION	dayaram	nn	9	SENT_12	[p2l968t313r1252b383],
9	T	NN	ORGANIZATION	t	appos	2	SENT_12	[p2l1274t313r1329b380],
10	,	,	O	,	_	0	SENT_12	[p2l1274t313r1329b380],
11	et	FW	O	et	nn	12	SENT_12	[p2l1359t321r1416b366],
12	al.	FW	O	al.	appos	2	SENT_12	[p2l1437t308r1508b367],
13	.	.	O	.	_	0	SENT_12	[p2l1437t308r1508b367],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_13	[p2l1535t313r1695b367],
2	mutation	NN	O	mutation	_	0	SENT_13	[p2l1715t309r2008b367],
3	and	CC	O	and	_	0	SENT_13	[p2l2032t308r2149b367],
4	resistance	NN	O	resistance	conj_and	2	SENT_13	[p2l19t405r336b463],
5	of	IN	O	of	_	0	SENT_13	[p2l359t404r435b464],
6	non	JJ	O	non	amod	10	SENT_13	[p2l443t404r918b464],
7	—	JJ	O	—	amod	10	SENT_13	[p2l443t404r918b464],
8	small-cell	NN	O	small-cell	nn	10	SENT_13	[p2l443t404r918b464],
9	lung	NN	O	lung	nn	10	SENT_13	[p2l940t404r1086b481],
10	cancer	NN	O	cancer	prep_of	2	SENT_13	[p2l1106t424r1313b463],
11	to	TO	O	to	_	0	SENT_13	[p2l1333t417r1393b464],
12	gefitinib	NN	O	gefitinib	prep_to	2	SENT_13	[p2l1416t404r1702b481],
13	.	.	O	.	_	0	SENT_13	[p2l1416t404r1702b481],

1	N	NN	O	n	nn	3	SENT_14	[p2l1727t410r1783b464],
2	Engl	NNP	O	Engl	nn	3	SENT_14	[p2l1803t404r1949b481],
3	J	NNP	O	J	nsubj	4	SENT_14	[p2l1964t409r1992b473],
4	Med	VBD	O	med	_	0	SENT_14	[p2l2010t404r2151b464],
5	2005	CD	DATE	2005	dobj	4	SENT_14	[p2l19t505r580b572],
6	;	:	O	;	_	0	SENT_14	[p2l19t505r580b572],
7	352:786	CD	NUMBER	352:786	number	8	SENT_14	[p2l19t505r580b572],
8	—	CD	NUMBER	—	dep	5	SENT_14	[p2l19t505r580b572],
9	92	CD	NUMBER	92	dep	8	SENT_14	[p2l19t505r580b572],
10	.	.	O	.	_	0	SENT_14	[p2l19t505r580b572],

1	3	LS	NUMBER	3	_	0	SENT_15	[p2l19t605r70b657],
2	.	.	O	.	_	0	SENT_15	[p2l19t605r70b657],

1	Pao	NNP	O	Pao	nn	2	SENT_16	[p2l147t602r260b657],
2	W	NNP	O	W	_	0	SENT_16	[p2l285t603r363b669],
3	,	,	O	,	_	0	SENT_16	[p2l285t603r363b669],
4	Miller	NNP	ORGANIZATION	Miller	nn	5	SENT_16	[p2l393t597r584b656],
5	VA	NNP	ORGANIZATION	VA	appos	2	SENT_16	[p2l606t603r711b669],
6	,	,	O	,	_	0	SENT_16	[p2l606t603r711b669],
7	Politi	NNP	PERSON	Politi	nn	8	SENT_16	[p2l742t597r907b657],
8	KA	NN	O	ka	appos	2	SENT_16	[p2l933t602r1046b669],
9	,	,	O	,	_	0	SENT_16	[p2l933t602r1046b669],
10	et	FW	O	et	nn	11	SENT_16	[p2l1078t610r1136b656],
11	al.	FW	O	al.	appos	2	SENT_16	[p2l1158t597r1229b657],
12	.	.	O	.	_	0	SENT_16	[p2l1158t597r1229b657],

1	Acquired	VBN	O	acquire	csubjpass	11	SENT_17	[p2l1258t597r1547b673],
2	resistance	NN	O	resistance	dobj	1	SENT_17	[p2l1573t598r1891b656],
3	of	IN	O	of	_	0	SENT_17	[p2l1918t597r1994b657],
4	lung	NN	O	lung	nn	5	SENT_17	[p2l2006t597r2152b674],
5	adenocarcinomas	NNS	O	adenocarcinoma	prep_of	2	SENT_17	[p2l18t694r579b754],
6	to	TO	O	to	_	0	SENT_17	[p2l607t707r667b754],
7	geﬁtinib	NN	O	geﬁtinib	prep_to	1	SENT_17	[p2l693t694r960b771],
8	or	CC	O	or	_	0	SENT_17	[p2l987t714r1055b754],
9	erlotinib	NN	O	erlotinib	prep_to	1	SENT_17	[p2l1078t694r1349b754],
10	is	VBZ	O	be	auxpass	11	SENT_17	[p2l1375t695r1424b753],
11	associated	VBN	O	associate	_	0	SENT_17	[p2l1451t694r1779b754],
12	with	IN	O	with	_	0	SENT_17	[p2l1801t694r1944b754],
13	a	DT	DURATION	a	det	15	SENT_17	[p2l1969t714r2003b753],
14	second	JJ	DURATION	second	amod	15	SENT_17	[p2l2029t714r2149b753, p2l19t791r141b850],
15	mutation	NN	O	mutation	prep_with	11	SENT_17	[p2l156t792r449b851],
16	in	IN	O	in	_	0	SENT_17	[p2l464t792r525b849],
17	the	DT	O	the	det	20	SENT_17	[p2l541t791r639b850],
18	EGFR	NN	ORGANIZATION	egfr	nn	20	SENT_17	[p2l653t795r848b853],
19	kinase	NN	O	kinase	nn	20	SENT_17	[p2l856t791r1059b851],
20	domain	NN	O	domain	prep_in	15	SENT_17	[p2l1075t791r1337b850],
21	.	.	O	.	_	0	SENT_17	[p2l1075t791r1337b850],

1	PLoS	NNP	O	PLoS	nn	2	SENT_18	[p2l1356t795r1512b850],
2	Med	NNP	O	Med	_	0	SENT_18	[p2l1527t791r1668b850],
3	2005	CD	DATE	2005	num	2	SENT_18	[p2l1683t795r1989b862],
4	;	:	O	;	_	0	SENT_18	[p2l1683t795r1989b862],
5	2	CD	NUMBER	2	number	6	SENT_18	[p2l1683t795r1989b862],
6	(	CD	NUMBER	(	dep	2	SENT_18	[p2l1683t795r1989b862],
7	3	CD	NUMBER	3	num	8	SENT_18	[p2l1683t795r1989b862],
8	)	NN	O	)	dep	6	SENT_18	[p2l1683t795r1989b862],
9	:	:	O	:	_	0	SENT_18	[p2l2000t795r2147b850],
10	e73	NN	O	e73	dep	6	SENT_18	[p2l2000t795r2147b850],
11	.	.	O	.	_	0	SENT_18	[p2l2000t795r2147b850],

1	4	LS	NUMBER	4	_	0	SENT_19	[p2l17t895r70b947],
2	.	.	O	.	_	0	SENT_19	[p2l17t895r70b947],

1	Sordella	NN	O	sordellum	nn	14	SENT_20	[p2l149t887r407b947],
2	R	NN	O	r	nn	14	SENT_20	[p2l426t892r491b960],
3	,	,	O	,	_	0	SENT_20	[p2l426t892r491b960],
4	Bell	NNP	ORGANIZATION	Bell	dep	14	SENT_20	[p2l516t887r636b946],
5	DW	NNP	ORGANIZATION	DW	nn	14	SENT_20	[p2l656t892r786b960],
6	,	,	O	,	_	0	SENT_20	[p2l656t892r786b960],
7	Haber	NNP	ORGANIZATION	Haber	appos	14	SENT_20	[p2l811t887r1008b947],
8	DA	NNP	ORGANIZATION	DA	nn	14	SENT_20	[p2l1026t892r1143b960],
9	,	,	O	,	_	0	SENT_20	[p2l1026t892r1143b960],
10	Settleman	NNP	O	Settleman	appos	14	SENT_20	[p2l1170t887r1486b947],
11	J.	NNP	O	J.	nn	14	SENT_20	[p2l1500t892r1544b956],
12	Geﬁtinibsensitizing	NNP	O	Geﬁtinibsensitizing	nn	14	SENT_20	[p2l1569t886r2149b947, p2l18t984r123b1059],
13	EGFR	NN	O	egfr	nn	14	SENT_20	[p2l151t987r346b1045],
14	mutations	NNS	O	mutation	nsubj	18	SENT_20	[p2l371t984r694b1042],
15	in	IN	O	in	_	0	SENT_20	[p2l728t984r789b1041],
16	lung	NN	O	lung	nn	17	SENT_20	[p2l821t983r967b1059],
17	cancer	NN	O	cancer	prep_in	14	SENT_20	[p2l997t1002r1205b1041],
18	activate	VBP	O	activate	_	0	SENT_20	[p2l1234t984r1470b1042],
19	anti-apoptotic	JJ	O	anti-apoptotic	amod	20	SENT_20	[p2l1502t984r1952b1058],
20	pathways	NNS	O	pathway	dobj	18	SENT_20	[p2l1982t983r2149b1058, p2l15t1098r188b1154],
21	.	.	O	.	_	0	SENT_20	[p2l1982t983r2149b1058, p2l15t1098r188b1154],

1	Science	NNP	O	Science	_	0	SENT_21	[p2l213t1080r447b1138],
2	2004	CD	DATE	2004	num	1	SENT_21	[p2l466t1083r1028b1150],
3	;	:	O	;	_	0	SENT_21	[p2l466t1083r1028b1150],
4	305:1163	CD	NUMBER	305:1163	number	5	SENT_21	[p2l466t1083r1028b1150],
5	-7	CD	NUMBER	-7	dep	1	SENT_21	[p2l466t1083r1028b1150],
6	.	.	O	.	_	0	SENT_21	[p2l466t1083r1028b1150],

1	5	CD	NUMBER	5	_	0	SENT_22	[p2l19t1181r70b1233],
2	.	.	O	.	_	0	SENT_22	[p2l19t1181r70b1233],

1	Marchetti	NNP	PERSON	Marchetti	nn	2	SENT_23	[p2l146t1174r454b1232],
2	A	NNP	O	A	_	0	SENT_23	[p2l477t1179r542b1245],
3	,	,	O	,	_	0	SENT_23	[p2l477t1179r542b1245],
4	Martella	NNP	PERSON	Martella	nn	5	SENT_23	[p2l571t1174r835b1232],
5	C	NNP	O	C	appos	2	SENT_23	[p2l862t1178r924b1245],
6	,	,	O	,	_	0	SENT_23	[p2l862t1178r924b1245],
7	Felicioni	NNP	O	Felicioni	nn	8	SENT_23	[p2l955t1174r1229b1233],
8	L	NNP	O	L	appos	2	SENT_23	[p2l1254t1179r1310b1246],
9	,	,	O	,	_	0	SENT_23	[p2l1254t1179r1310b1246],
10	et	FW	O	et	nn	11	SENT_23	[p2l1342t1187r1399b1232],
11	al.	FW	O	al.	appos	2	SENT_23	[p2l1422t1174r1493b1233],
12	.	.	O	.	_	0	SENT_23	[p2l1422t1174r1493b1233],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_24	[p2l1523t1178r1718b1236],
2	mutations	NNS	O	mutation	_	0	SENT_24	[p2l1738t1175r2060b1233],
3	in	IN	O	in	_	0	SENT_24	[p2l2088t1175r2149b1232],
4	non	JJ	O	non	amod	8	SENT_24	[p2l19t1270r481b1330],
5	—	JJ	O	—	amod	8	SENT_24	[p2l19t1270r481b1330],
6	small-cell	NN	O	small-cell	nn	8	SENT_24	[p2l19t1270r481b1330],
7	lung	NN	O	lung	nn	8	SENT_24	[p2l507t1270r653b1347],
8	cancer	NN	O	cancer	prep_in	2	SENT_24	[p2l678t1290r902b1330],
9	:	:	O	:	_	0	SENT_24	[p2l678t1290r902b1330],
10	analysis	NN	O	analysis	dep	2	SENT_24	[p2l932t1270r1181b1346],
11	of	IN	O	of	_	0	SENT_24	[p2l1211t1270r1287b1330],
12	a	DT	O	a	det	14	SENT_24	[p2l1299t1290r1333b1329],
13	large	JJ	O	large	amod	14	SENT_24	[p2l1359t1270r1516b1347],
14	series	NN	O	series	prep_of	10	SENT_24	[p2l1545t1271r1721b1329],
15	of	IN	O	of	_	0	SENT_24	[p2l1752t1270r1827b1330],
16	cases	NNS	O	case	prep_of	14	SENT_24	[p2l1841t1290r2005b1329],
17	and	CC	O	and	_	0	SENT_24	[p2l2034t1270r2151b1330],
18	development	NN	O	development	prep_of	14	SENT_24	[p2l19t1367r433b1443],
19	of	IN	O	of	_	0	SENT_24	[p2l449t1366r525b1427],
20	a	DT	O	a	det	24	SENT_24	[p2l531t1387r564b1426],
21	rapid	JJ	O	rapid	amod	24	SENT_24	[p2l583t1367r747b1443],
22	and	CC	O	and	_	0	SENT_24	[p2l766t1367r884b1427],
23	sensitive	JJ	O	sensitive	conj_and	21	SENT_24	[p2l905t1368r1175b1427],
24	method	NN	O	method	prep_of	10	SENT_24	[p2l1195t1367r1441b1427],
25	for	IN	O	for	_	0	SENT_24	[p2l1461t1367r1553b1427],
26	diagnostic	JJ	O	diagnostic	amod	27	SENT_24	[p2l1572t1367r1902b1444],
27	screening	NN	O	screening	prep_for	24	SENT_24	[p2l1923t1387r2149b1426, p2l18t1465r123b1540],
28	with	IN	O	with	_	0	SENT_24	[p2l139t1464r281b1523],
29	potential	JJ	O	potential	amod	30	SENT_24	[p2l302t1464r585b1539],
30	implications	NNS	O	implication	prep_with	27	SENT_24	[p2l606t1464r1002b1539],
31	on	IN	O	on	_	0	SENT_24	[p2l1027t1483r1107b1523],
32	pharmacologic	JJ	O	pharmacologic	amod	33	SENT_24	[p2l1128t1464r1608b1540],
33	treatment	NN	O	treatment	prep_on	30	SENT_24	[p2l1630t1477r1955b1523],
34	.	.	O	.	_	0	SENT_24	[p2l1630t1477r1955b1523],

1	JClin	NN	O	jclin	nn	2	SENT_25	[p2l1974t1464r2149b1532],
2	Oncol	NN	O	oncol	_	0	SENT_25	[p2l19t1560r210b1620],
3	2005	CD	DATE	2005	dep	2	SENT_25	[p2l228t1564r750b1630],
4	;	:	O	;	_	0	SENT_25	[p2l228t1564r750b1630],
5	23:857	CD	NUMBER	23:857	number	6	SENT_25	[p2l228t1564r750b1630],
6	—	CD	NUMBER	—	dep	2	SENT_25	[p2l228t1564r750b1630],
7	65	CD	NUMBER	65	dep	6	SENT_25	[p2l228t1564r750b1630],
8	.	.	O	.	_	0	SENT_25	[p2l228t1564r750b1630],

1	Responsiveness	NN	O	responsiveness	_	0	SENT_26	[p2l313t1706r733b1768],
2	to	TO	O	to	_	0	SENT_26	[p2l750t1713r802b1754],
3	Cetuximab	NNP	O	Cetuximab	prep_to	1	SENT_26	[p2l820t1705r1102b1754],
4	without	IN	O	without	dep	1	SENT_26	[p2l1119t1705r1324b1754],
5	Mutations	NNS	O	mutation	pobj	4	SENT_26	[p2l1344t1706r1612b1754],
6	in	IN	O	in	dep	1	SENT_26	[p2l1633t1706r1677b1753],
7	EGFR	NN	ORGANIZATION	egfr	pobj	6	SENT_26	[p2l1697t1709r1846b1754],

1	TO	TO	O	to	aux	4	SENT_27	[p2l7t1917r107b1966],
2	TH	NN	O	th	nn	4	SENT_27	[p2l136t1917r234b1965],
3	E	NN	O	e	nn	4	SENT_27	[p2l254t1917r287b1965],
4	EDITOR	NN	O	editor	csubjpass	54	SENT_27	[p2l323t1916r627b1967],
5	:	:	O	:	_	0	SENT_27	[p2l323t1916r627b1967],
6	A	DT	O	a	det	8	SENT_27	[p2l653t1895r720b1965],
7	large	JJ	O	large	amod	8	SENT_27	[p2l744t1888r950b1990],
8	amount	NN	O	amount	nsubj	11	SENT_27	[p2l977t1904r1307b1968],
9	of	IN	O	of	_	0	SENT_27	[p2l1329t1887r1429b1967],
10	information	NN	O	information	prep_of	8	SENT_27	[p2l1436t1887r1940b1967],
11	suggests	VBZ	O	suggest	dep	4	SENT_27	[p2l1969t1914r2146b1990, p2l8t2034r217b2119],
12	that	IN	O	that	complm	27	SENT_27	[p2l247t2017r413b2096],
13	mutations	NNS	O	mutation	nsubj	27	SENT_27	[p2l439t2018r881b2097],
14	in	IN	O	in	_	0	SENT_27	[p2l914t2018r998b2094],
15	the	DT	O	the	det	17	SENT_27	[p2l1030t2017r1161b2096],
16	kinase	NN	O	kinase	nn	17	SENT_27	[p2l1193t2017r1470b2097],
17	domain	NN	O	domain	prep_in	13	SENT_27	[p2l1503t2017r1835b2096],
18	of	IN	O	of	_	0	SENT_27	[p2l1867t2016r1969b2096],
19	epidermal	JJ	O	epidermal	amod	21	SENT_27	[p2l1983t2018r2144b2118, p2l9t2146r312b2225],
20	growth	NN	O	growth	nn	21	SENT_27	[p2l340t2146r650b2248],
21	factor	NN	O	factor	prep_of	17	SENT_27	[p2l678t2145r932b2225],
22	receptor	NN	O	receptor	nn	25	SENT_27	[p2l957t2163r1318b2247],
23	(	CD	NUMBER	(	num	25	SENT_27	[p2l1348t2151r1661b2238],
24	EGFR	NN	ORGANIZATION	egfr	nn	25	SENT_27	[p2l1348t2151r1661b2238],
25	)	NN	O	)	dep	21	SENT_27	[p2l1348t2151r1661b2238],
26	are	VBP	O	be	cop	27	SENT_27	[p2l1695t2172r1823b2225],
27	critical	JJ	O	critical	ccomp	11	SENT_27	[p2l1853t2146r2146b2225],
28	for	IN	O	for	_	0	SENT_27	[p2l8t2274r134b2353],
29	the	DT	O	the	det	30	SENT_27	[p2l194t2275r327b2353],
30	efﬁcacy	NN	O	efﬁcacy	prep_for	27	SENT_27	[p2l390t2274r718b2375],
31	of	IN	O	of	_	0	SENT_27	[p2l777t2274r878b2353],
32	EGFR	NN	ORGANIZATION	egfr	nn	34	SENT_27	[p2l921t2280r1185b2358],
33	kinase	NN	O	kinase	nn	34	SENT_27	[p2l1236t2275r1513b2354],
34	inhibitors	NNS	O	inhibitor	prep_of	30	SENT_27	[p2l1575t2275r2143b2353],
35	.1	CD	NUMBER	.1	number	36	SENT_27	[p2l1575t2275r2143b2353],
36	‘	CD	NUMBER	‘	amod	34	SENT_27	[p2l1575t2275r2143b2353],
37	3	CD	NUMBER	3	dep	36	SENT_27	[p2l1575t2275r2143b2353],
38	However	RB	O	however	advmod	27	SENT_27	[p2l8t2410r410b2499],
39	,	,	O	,	_	0	SENT_27	[p2l8t2410r410b2499],
40	the	DT	O	the	det	41	SENT_27	[p2l449t2403r581b2481],
41	effect	NN	O	effect	attr	27	SENT_27	[p2l616t2402r856b2481],
42	of	IN	O	of	_	0	SENT_27	[p2l886t2402r987b2481],
43	EGFR	NN	ORGANIZATION	egfr	nn	44	SENT_27	[p2l1000t2410r1217b2482],
44	mutations	NNS	O	mutation	prep_of	41	SENT_27	[p2l1244t2404r1686b2482],
45	on	IN	O	on	_	0	SENT_27	[p2l1722t2429r1830b2481],
46	the	DT	O	the	det	47	SENT_27	[p2l1864t2403r1996b2481],
47	response	NN	O	response	prep_on	4	SENT_27	[p2l2029t2429r2144b2481, p2l11t2558r311b2632],
48	to	TO	O	to	_	0	SENT_27	[p2l338t2548r419b2610],
49	Cetuximab	NNP	LOCATION	Cetuximab	prep_to	4	SENT_27	[p2l446t2532r891b2611],
50	has	VBZ	O	have	aux	54	SENT_27	[p2l918t2532r1063b2610],
51	not	RB	O	not	neg	54	SENT_27	[p2l1090t2548r1237b2610],
52	been	VBN	O	be	auxpass	54	SENT_27	[p2l1257t2532r1461b2610],
53	directly	RB	O	directly	advmod	54	SENT_27	[p2l1488t2532r1809b2632],
54	investigated	VBN	O	investigate	_	0	SENT_27	[p2l1829t2533r2144b2611, p2l8t2660r268b2762],
55	.	.	O	.	_	0	SENT_27	[p2l1829t2533r2144b2611, p2l8t2660r268b2762],

1	Barber	NNP	O	Barber	nsubj	15	SENT_28	[p2l300t2660r591b2739],
2	et	FW	O	et	nn	3	SENT_28	[p2l618t2676r696b2739],
3	al.	FW	O	al.	dep	1	SENT_28	[p2l719t2660r864b2739],
4	4	CD	NUMBER	4	dep	1	SENT_28	[p2l719t2660r864b2739],
5	reported	VBD	O	report	_	0	SENT_28	[p2l892t2660r1261b2761],
6	the	DT	O	the	det	7	SENT_28	[p2l1290t2660r1422b2739],
7	absence	NN	O	absence	dobj	5	SENT_28	[p2l1450t2660r1795b2739],
8	of	IN	O	of	_	0	SENT_28	[p2l1824t2659r1926b2739],
9	EGFR	NN	ORGANIZATION	egfr	nn	10	SENT_28	[p2l1934t2667r2152b2740],
10	mutations	NNS	O	mutation	prep_of	7	SENT_28	[p2l8t2791r450b2869],
11	in	IN	O	in	_	0	SENT_28	[p2l500t2791r583b2867],
12	colorectal	JJ	O	colorectal	amod	13	SENT_28	[p2l632t2790r1058b2868],
13	cancers	NNS	O	cancer	prep_in	5	SENT_28	[p2l1106t2816r1428b2868],
14	and	CC	O	and	_	0	SENT_28	[p2l1478t2790r1637b2868],
15	speculated	VBD	O	speculate	conj_and	5	SENT_28	[p2l1687t2790r2145b2890],
16	that	IN	O	that	complm	21	SENT_28	[p2l9t2918r180b2996],
17	EGFR	NN	ORGANIZATION	egfr	nn	18	SENT_28	[p2l203t2925r420b2997],
18	mutations	NNS	O	mutation	nsubjpass	21	SENT_28	[p2l443t2919r885b2997],
19	were	VBD	O	be	auxpass	21	SENT_28	[p2l913t2944r1118b2997],
20	not	RB	O	not	neg	21	SENT_28	[p2l1148t2935r1295b2996],
21	required	VBN	O	require	ccomp	15	SENT_28	[p2l1319t2918r1685b3018],
22	for	IN	O	for	_	0	SENT_28	[p2l1714t2917r1840b2996],
23	the	DT	O	the	det	24	SENT_28	[p2l1867t2918r2000b2996],
24	response	NN	O	response	prep_for	21	SENT_28	[p2l2029t2944r2144b2996, p2l11t3072r311b3146],
25	to	TO	O	to	_	0	SENT_28	[p2l351t3063r431b3124],
26	cetuximab	NN	O	cetuximab	prep_to	21	SENT_28	[p2l472t3046r943b3141],
27	,	,	O	,	_	0	SENT_28	[p2l472t3046r943b3141],
28	since	IN	O	since	mark	33	SENT_28	[p2l988t3047r1207b3124],
29	it	PRP	O	it	nsubj	33	SENT_28	[p2l1245t3047r1306b3124],
30	was	VBD	O	be	cop	33	SENT_28	[p2l1335t3072r1499b3125],
31	an	DT	O	a	det	33	SENT_28	[p2l1539t3072r1640b3124],
32	efﬁcacious	JJ	O	efﬁcacious	amod	33	SENT_28	[p2l1679t3045r2143b3125],
33	agent	NN	O	agent	advcl	21	SENT_28	[p2l8t3191r251b3276],
34	against	IN	O	against	_	0	SENT_28	[p2l281t3175r598b3276],
35	this	DT	O	this	det	36	SENT_28	[p2l629t3174r785b3253],
36	type	NN	O	type	prep_against	33	SENT_28	[p2l823t3190r998b3275],
37	of	IN	O	of	_	0	SENT_28	[p2l1034t3173r1136b3253],
38	tumor	NN	O	tumor	prep_of	36	SENT_28	[p2l1153t3180r1483b3254],
39	.5	CD	NUMBER	.5	num	38	SENT_28	[p2l1153t3180r1483b3254],
40	We	PRP	O	we	nsubj	41	SENT_28	[p2l1518t3181r1653b3253],
41	sequenced	VBD	O	sequence	rcmod	33	SENT_28	[p2l1691t3174r2145b3275],
42	the	DT	O	the	det	44	SENT_28	[p2l9t3303r141b3381],
43	kinase	NN	O	kinase	nn	44	SENT_28	[p2l169t3303r447b3382],
44	domain	NN	O	domain	nsubj	48	SENT_28	[p2l476t3303r807b3381],
45	of	IN	O	of	_	0	SENT_28	[p2l836t3302r938b3381],
46	EGFR	NN	ORGANIZATION	egfr	prep_of	44	SENT_28	[p2l945t3310r1163b3382],
47	(	CD	NUMBER	(	num	46	SENT_28	[p2l1189t3310r1468b3394],
48	exons	NNS	O	exon	xcomp	41	SENT_28	[p2l1189t3310r1468b3394],
49	18	CD	NUMBER	18	num	48	SENT_28	[p2l1501t3308r1625b3399],
50	,	,	O	,	_	0	SENT_28	[p2l1501t3308r1625b3399],
51	19	CD	NUMBER	19	num	48	SENT_28	[p2l1662t3308r1786b3399],
52	,	,	O	,	_	0	SENT_28	[p2l1662t3308r1786b3399],
53	and	CC	NUMBER	and	_	0	SENT_28	[p2l1819t3303r1978b3381],
54	21	CD	NUMBER	21	conj_and	48	SENT_28	[p2l2006t3308r2139b3394],
55	)	NN	O	)	dobj	5	SENT_28	[p2l2006t3308r2139b3394],
56	in	IN	O	in	_	0	SENT_28	[p2l8t3432r91b3508],
57	tumor	NN	O	tumor	nn	58	SENT_28	[p2l128t3448r396b3511],
58	samples	NNS	O	sample	prep_in	5	SENT_28	[p2l431t3431r782b3532],
59	from	IN	O	from	_	0	SENT_28	[p2l820t3430r1032b3510],
60	38	CD	NUMBER	38	num	61	SENT_28	[p2l1069t3436r1169b3511],
61	patients	NNS	O	patient	prep_from	5	SENT_28	[p2l1205t3432r1550b3532],
62	participating	VBG	O	participate	partmod	61	SENT_28	[p2l1587t3432r2149b3533],
63	in	IN	O	in	_	0	SENT_28	[p2l8t3561r91b3637],
64	a	DT	O	a	det	68	SENT_28	[p2l129t3586r173b3638],
65	cetuXimab	JJ	O	cetuximab	amod	68	SENT_28	[p2l211t3560r1285b3660],
66	—	NN	O	—	nn	68	SENT_28	[p2l211t3560r1285b3660],
67	monotherapy	NN	O	monotherapy	nn	68	SENT_28	[p2l211t3560r1285b3660],
68	study	NN	O	study	prep_in	62	SENT_28	[p2l1321t3560r1552b3660],
69	for	IN	O	for	_	0	SENT_28	[p2l1585t3559r1712b3638],
70	recurrent	JJ	O	recurrent	amod	75	SENT_28	[p2l1746t3576r2150b3639],
71	non	JJ	O	non	amod	75	SENT_28	[p2l8t3688r659b3766],
72	—	NN	O	—	nn	75	SENT_28	[p2l8t3688r659b3766],
73	small-cell	NN	O	small-cell	nn	75	SENT_28	[p2l8t3688r659b3766],
74	lung	NN	O	lung	nn	75	SENT_28	[p2l704t3688r903b3789],
75	cancer	NN	O	cancer	prep_for	68	SENT_28	[p2l947t3713r1229b3766],
76	and	CC	O	and	_	0	SENT_28	[p2l1272t3688r1431b3766],
77	tumor	NN	O	tumor	nn	78	SENT_28	[p2l1478t3704r1747b3767],
78	samples	NNS	O	sample	prep_for	68	SENT_28	[p2l1792t3688r2143b3788],
79	from	IN	O	from	_	0	SENT_28	[p3l8t20r220b100],
80	39	CD	NUMBER	39	num	81	SENT_28	[p3l273t27r374b101],
81	patients	NNS	O	patient	prep_from	62	SENT_28	[p3l426t22r770b122],
82	participating	VBG	O	participate	partmod	81	SENT_28	[p3l822t22r1385b123],
83	in	IN	O	in	_	0	SENT_28	[p3l1432t22r1516b98],
84	a	DT	O	a	det	88	SENT_28	[p3l1567t47r1612b100],
85	cetuximab	JJ	O	cetuximab	amod	88	SENT_28	[p3l1662t21r2144b101],
86	—	NN	O	—	nn	88	SENT_28	[p3l1662t21r2144b101],
87	monotherapy	NN	O	monotherapy	nn	88	SENT_28	[p3l8t150r594b250],
88	study	NN	O	study	prep_in	82	SENT_28	[p3l626t150r858b250],
89	for	IN	O	for	_	0	SENT_28	[p3l888t149r1014b228],
90	refractory	JJ	O	refractory	amod	92	SENT_28	[p3l1047t149r1470b250],
91	colorectal	JJ	O	colorectal	amod	92	SENT_28	[p3l1501t150r1927b228],
92	cancer	NN	O	cancer	prep_for	88	SENT_28	[p3l1962t176r2144b228, p3l9t305r155b357],
93	.	.	O	.	_	0	SENT_28	[p3l1962t176r2144b228, p3l9t305r155b357],

1	Mutations	NNS	O	mutation	nsubjpass	15	SENT_29	[p3l190t280r634b358],
2	previously	RB	DATE	previously	advmod	3	SENT_29	[p3l668t279r1114b379],
3	detected	VBN	O	detect	partmod	1	SENT_29	[p3l1142t279r1502b357],
4	in	IN	O	in	_	0	SENT_29	[p3l1533t280r1616b356],
5	non	JJ	O	non	amod	11	SENT_29	[p3l1648t279r2144b357],
6	—	JJ	O	—	amod	11	SENT_29	[p3l1648t279r2144b357],
7	small	JJ	O	small	amod	11	SENT_29	[p3l1648t279r2144b357],
8	—	NN	O	—	nn	11	SENT_29	[p3l1648t279r2144b357],
9	cell	NN	O	cell	nn	11	SENT_29	[p3l9t407r155b486],
10	lung	NN	O	lung	nn	11	SENT_29	[p3l191t407r390b509],
11	cancer1	NN	O	cancer1	prep_in	3	SENT_29	[p3l425t412r814b486],
12	'	''	O	'	_	0	SENT_29	[p3l425t412r814b486],
13	3	CD	NUMBER	3	dep	11	SENT_29	[p3l425t412r814b486],
14	were	VBD	O	be	auxpass	15	SENT_29	[p3l849t433r1055b487],
15	identified	VBN	O	identify	_	0	SENT_29	[p3l1093t406r1509b486],
16	in	IN	O	in	_	0	SENT_29	[p3l1546t408r1629b484],
17	3	CD	NUMBER	3	prep_in	15	SENT_29	[p3l1668t413r1712b487],
18	of	IN	O	of	_	0	SENT_29	[p3l1754t406r1856b486],
19	the	DT	O	the	det	21	SENT_29	[p3l1876t407r2008b486],
20	38	CD	NUMBER	38	num	21	SENT_29	[p3l2048t412r2145b487],
21	patients	NNS	O	patient	prep_of	17	SENT_29	[p3l7t537r337b637],
22	with	IN	O	with	_	0	SENT_29	[p3l361t536r550b616],
23	non	JJ	O	non	amod	29	SENT_29	[p3l576t536r1200b615],
24	—	JJ	O	—	amod	29	SENT_29	[p3l576t536r1200b615],
25	small	JJ	O	small	amod	29	SENT_29	[p3l576t536r1200b615],
26	—	NN	O	—	nn	29	SENT_29	[p3l576t536r1200b615],
27	cell	NN	O	cell	nn	29	SENT_29	[p3l576t536r1200b615],
28	lung	NN	O	lung	nn	29	SENT_29	[p3l1225t536r1417b638],
29	cancer	NN	O	cancer	prep_with	15	SENT_29	[p3l1441t562r1729b615],
30	.	.	O	.	_	0	SENT_29	[p3l1441t562r1729b615],

1	Of	IN	O	of	_	0	SENT_30	[p3l1761t535r1881b615],
2	13	CD	NUMBER	13	num	3	SENT_30	[p3l1892t541r1986b616],
3	patients	NNS	O	patient	prep_of	18	SENT_30	[p3l2014t562r2146b637, p3l9t666r246b743],
4	With	IN	O	with	_	0	SENT_30	[p3l268t665r462b744],
5	non	JJ	O	non	amod	11	SENT_30	[p3l486t665r1137b743],
6	—	JJ	O	—	amod	11	SENT_30	[p3l486t665r1137b743],
7	small	JJ	O	small	amod	11	SENT_30	[p3l486t665r1137b743],
8	—	NN	O	—	nn	11	SENT_30	[p3l486t665r1137b743],
9	cell	NN	O	cell	nn	11	SENT_30	[p3l486t665r1137b743],
10	lung	NN	O	lung	nn	11	SENT_30	[p3l1160t665r1359b766],
11	cancer	NN	O	cancer	prep_with	18	SENT_30	[p3l1380t691r1663b743],
12	whose	WP$	O	whose	poss	13	SENT_30	[p3l1680t665r1960b744],
13	disease	NN	O	disease	nsubj	15	SENT_30	[p3l1986t665r2144b743, p3l9t819r190b871],
14	Was	VBD	O	be	cop	15	SENT_30	[p3l214t819r378b872],
15	stable	JJ	O	stable	rcmod	11	SENT_30	[p3l410t793r689b889],
16	,	,	O	,	_	0	SENT_30	[p3l410t793r689b889],
17	2	CD	NUMBER	2	nsubj	18	SENT_30	[p3l722t798r770b870],
18	carried	VBD	O	carry	_	0	SENT_30	[p3l800t793r1098b871],
19	a	DT	O	a	det	21	SENT_30	[p3l1126t819r1170b871],
20	del746	JJ	O	del746	amod	21	SENT_30	[p3l1197t793r1710b889],
21	—	NN	O	—	dobj	18	SENT_30	[p3l1197t793r1710b889],
22	750	CD	NUMBER	750	num	21	SENT_30	[p3l1197t793r1710b889],
23	,	,	O	,	_	0	SENT_30	[p3l1197t793r1710b889],
24	and	CC	O	and	_	0	SENT_30	[p3l1744t793r1903b871],
25	of	IN	O	of	_	0	SENT_30	[p3l1931t792r2033b871],
26	21	CD	NUMBER	21	num	27	SENT_30	[p3l2042t798r2145b870],
27	patients	NNS	O	patient	prep_of	33	SENT_30	[p3l7t921r351b1021],
28	with	IN	O	with	_	0	SENT_30	[p3l373t921r567b1000],
29	progressive	JJ	O	progressive	amod	30	SENT_30	[p3l589t922r1088b1022],
30	disease	NN	O	disease	prep_with	27	SENT_30	[p3l1113t921r1450b1017],
31	,	,	O	,	_	0	SENT_30	[p3l1113t921r1450b1017],
32	1	CD	NUMBER	1	nsubj	33	SENT_30	[p3l1482t926r1527b998],
33	had	VBD	O	have	conj_and	18	SENT_30	[p3l1551t921r1709b999],
34	an	DT	O	a	det	36	SENT_30	[p3l1732t946r1835b999],
35	L861Q	NN	O	l861q	nn	36	SENT_30	[p3l1857t926r2153b1018],
36	mutation	NN	O	mutation	dobj	33	SENT_30	[p3l8t1050r433b1128],
37	.	.	O	.	_	0	SENT_30	[p3l8t1050r433b1128],

1	N	NN	O	n	nn	3	SENT_31	[p3l471t1056r546b1128],
2	o	NN	O	o	nn	3	SENT_31	[p3l551t1074r599b1127],
3	mutations	NNS	O	mutation	nsubjpass	5	SENT_31	[p3l635t1050r1077b1128],
4	were	VBD	O	be	auxpass	5	SENT_31	[p3l1110t1075r1316b1128],
5	identiﬁed	VBN	O	identiﬁed	_	0	SENT_31	[p3l1350t1048r1766b1127],
6	in	IN	O	in	_	0	SENT_31	[p3l1800t1050r1883b1126],
7	other	JJ	O	other	amod	8	SENT_31	[p3l1919t1049r2148b1127],
8	patients	NNS	O	patient	prep_in	5	SENT_31	[p3l7t1177r351b1277],
9	With	IN	O	with	_	0	SENT_31	[p3l372t1177r566b1256],
10	non	JJ	O	non	amod	16	SENT_31	[p3l588t1177r1239b1255],
11	—	JJ	O	—	amod	16	SENT_31	[p3l588t1177r1239b1255],
12	small	JJ	O	small	amod	16	SENT_31	[p3l588t1177r1239b1255],
13	—	NN	O	—	nn	16	SENT_31	[p3l588t1177r1239b1255],
14	cell	NN	O	cell	nn	16	SENT_31	[p3l588t1177r1239b1255],
15	lung	NN	O	lung	nn	16	SENT_31	[p3l1260t1177r1459b1278],
16	cancer	NN	O	cancer	prep_with	5	SENT_31	[p3l1479t1202r1761b1255],
17	who	WP	O	who	nsubj	18	SENT_31	[p3l1776t1177r1963b1256],
18	had	VBD	O	have	rcmod	16	SENT_31	[p3l1987t1177r2145b1255],
19	a	DT	O	a	det	21	SENT_31	[p3l9t1331r54b1383],
20	partial	JJ	O	partial	amod	21	SENT_31	[p3l88t1305r366b1405],
21	response	NN	O	response	nsubj	23	SENT_31	[p3l403t1331r789b1405],
22	(	CD	NUMBER	(	num	23	SENT_31	[p3l831t1312r1017b1396],
23	one	CD	NUMBER	one	xcomp	18	SENT_31	[p3l831t1312r1017b1396],
24	patient	NN	O	patient	dep	23	SENT_31	[p3l1053t1306r1383b1405],
25	)	CD	NUMBER	)	num	24	SENT_31	[p3l1053t1306r1383b1405],
26	or	CC	O	or	_	0	SENT_31	[p3l1426t1331r1516b1384],
27	for	IN	O	for	dep	23	SENT_31	[p3l1551t1304r1676b1384],
28	whom	WP	O	whom	nsubj	29	SENT_31	[p3l1706t1305r1981b1385],
29	response	VBP	O	response	pcomp	27	SENT_31	[p3l2018t1331r2132b1383, p3l12t1458r311b1532],
30	data	NNS	O	datum	nsubj	33	SENT_31	[p3l340t1433r522b1511],
31	Were	VBD	O	be	cop	33	SENT_31	[p3l543t1459r749b1512],
32	unavailable	JJ	O	unavailable	amod	33	SENT_31	[p3l776t1433r1262b1512],
33	(	NN	O	(	ccomp	29	SENT_31	[p3l1295t1433r1543b1523],
34	three	CD	NUMBER	three	num	35	SENT_31	[p3l1295t1433r1543b1523],
35	patients	NNS	O	patient	tmod	18	SENT_31	[p3l1569t1434r1973b1532],
36	)	CD	NUMBER	)	dep	35	SENT_31	[p3l1569t1434r1973b1532],
37	.	.	O	.	_	0	SENT_31	[p3l1569t1434r1973b1532],

1	N	NN	O	n	nn	3	SENT_32	[p3l2004t1440r2079b1512],
2	o	NN	O	o	nn	3	SENT_32	[p3l2084t1458r2132b1511],
3	mutations	NNS	O	mutation	nsubjpass	5	SENT_32	[p3l10t1562r449b1640],
4	were	VBD	O	be	auxpass	5	SENT_32	[p3l478t1587r682b1641],
5	detected	VBN	O	detect	_	0	SENT_32	[p3l714t1561r1071b1640],
6	in	IN	O	in	_	0	SENT_32	[p3l1102t1562r1184b1638],
7	the	DT	O	the	det	8	SENT_32	[p3l1215t1561r1346b1639],
8	samples	NNS	O	sample	prep_in	5	SENT_32	[p3l1378t1561r1727b1661],
9	from	IN	O	from	_	0	SENT_32	[p3l1760t1560r1970b1640],
10	the	DT	O	the	det	12	SENT_32	[p3l2001t1561r2133b1639],
11	39	CD	NUMBER	39	num	12	SENT_32	[p3l11t1694r110b1768],
12	patients	NNS	O	patient	prep_from	8	SENT_32	[p3l136t1690r471b1789],
13	with	IN	O	with	_	0	SENT_32	[p3l496t1689r684b1768],
14	colorectal	JJ	O	colorectal	amod	15	SENT_32	[p3l712t1689r1126b1768],
15	cancer	NN	O	cancer	prep_with	5	SENT_32	[p3l1153t1715r1444b1785],
16	,	,	O	,	_	0	SENT_32	[p3l1153t1715r1444b1785],
17	including	VBG	O	include	_	0	SENT_32	[p3l1476t1689r1883b1790],
18	those	DT	O	those	prep_including	5	SENT_32	[p3l1907t1689r2134b1768],
19	from	IN	O	from	_	0	SENT_32	[p3l10t1816r222b1896],
20	20	CD	NUMBER	20	num	21	SENT_32	[p3l253t1823r355b1896],
21	patients	NNS	O	patient	prep_from	18	SENT_32	[p3l385t1818r732b1917],
22	who	WP	O	who	nsubj	23	SENT_32	[p3l760t1817r947b1896],
23	had	VBD	O	have	rcmod	21	SENT_32	[p3l979t1817r1138b1896],
24	a	DT	O	a	det	26	SENT_32	[p3l1168t1843r1213b1895],
25	partial	JJ	O	partial	amod	26	SENT_32	[p3l1241t1817r1521b1917],
26	response	NN	O	response	dobj	23	SENT_32	[p3l1552t1843r1943b1917],
27	and	CC	O	and	_	0	SENT_32	[p3l1974t1817r2133b1896],
28	1	CD	NUMBER	1	dobj	23	SENT_32	[p3l13t1950r57b2021],
29	Who	WP	O	who	nsubj	30	SENT_32	[p3l81t1945r266b2024],
30	had	VBD	O	have	rcmod	28	SENT_32	[p3l296t1945r452b2023],
31	a	DT	O	a	det	33	SENT_32	[p3l479t1971r523b2022],
32	complete	JJ	O	complete	amod	33	SENT_32	[p3l550t1945r946b2044],
33	response	NN	O	response	dobj	30	SENT_32	[p3l974t1970r1386b2044],
34	.	.	O	.	_	0	SENT_32	[p3l974t1970r1386b2044],

1	From	IN	O	from	_	0	SENT_33	[p3l137t2080r366b2151],
2	these	DT	O	these	det	3	SENT_33	[p3l394t2073r613b2150],
3	results	NNS	O	result	prep_from	6	SENT_33	[p3l641t2073r944b2168],
4	,	,	O	,	_	0	SENT_33	[p3l641t2073r944b2168],
5	it	PRP	O	it	nsubj	6	SENT_33	[p3l976t2074r1036b2150],
6	appears	VBZ	O	appear	_	0	SENT_33	[p3l1058t2099r1385b2172],
7	that	IN	O	that	complm	19	SENT_33	[p3l1415t2073r1582b2150],
8	the	DT	O	the	det	9	SENT_33	[p3l1605t2073r1734b2150],
9	presence	NN	O	presence	nsubj	19	SENT_33	[p3l1760t2098r2134b2172],
10	of	IN	O	of	_	0	SENT_33	[p3l11t2200r111b2280],
11	an	DT	O	a	det	13	SENT_33	[p3l133t2227r234b2279],
12	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_33	[p3l274t2208r486b2280],
13	mutation	NN	O	mutation	prep_of	9	SENT_33	[p3l521t2202r910b2280],
14	is	VBZ	O	be	cop	19	SENT_33	[p3l951t2202r1016b2279],
15	not	RB	O	not	neg	19	SENT_33	[p3l1060t2218r1204b2280],
16	a	DT	O	a	det	19	SENT_33	[p3l1240t2227r1284b2279],
17	major	JJ	O	major	amod	19	SENT_33	[p3l1324t2202r1572b2301],
18	determining	NN	O	determining	nn	19	SENT_33	[p3l1612t2201r2137b2302],
19	factor	NN	O	factor	ccomp	6	SENT_33	[p3l10t2328r256b2408],
20	for	IN	O	for	_	0	SENT_33	[p3l298t2328r421b2408],
21	a	DT	O	a	det	23	SENT_33	[p3l464t2355r508b2407],
22	positive	JJ	O	positive	amod	23	SENT_33	[p3l551t2330r877b2429],
23	response	NN	O	response	prep_for	19	SENT_33	[p3l923t2355r1302b2429],
24	to	TO	O	to	_	0	SENT_33	[p3l1348t2346r1427b2408],
25	cetuximab	NN	O	cetuximab	prep_to	23	SENT_33	[p3l1475t2329r1934b2408],
26	.	.	O	.	_	0	SENT_33	[p3l1475t2329r1934b2408],

1	Absence	NN	O	absence	nsubj	24	SENT_34	[p3l1982t2329r2133b2408, p3l12t2483r243b2535],
2	of	IN	O	of	_	0	SENT_34	[p3l273t2456r373b2536],
3	an	DT	O	a	det	5	SENT_34	[p3l384t2483r484b2535],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_34	[p3l512t2464r724b2537],
5	mutation	NN	O	mutation	prep_of	1	SENT_34	[p3l747t2458r1136b2536],
6	in	IN	O	in	_	0	SENT_34	[p3l1165t2458r1246b2534],
7	the	DT	O	the	det	8	SENT_34	[p3l1276t2457r1405b2535],
8	samples	NNS	O	sample	prep_in	5	SENT_34	[p3l1436t2457r1778b2557],
9	of	IN	O	of	_	0	SENT_34	[p3l1811t2456r1911b2536],
10	colorectal	JJ	O	colorectal	amod	11	SENT_34	[p3l1923t2457r2133b2536, p3l10t2585r242b2663],
11	cancer	NN	O	cancer	prep_of	8	SENT_34	[p3l283t2611r574b2681],
12	,	,	O	,	_	0	SENT_34	[p3l283t2611r574b2681],
13	including	VBG	O	include	_	0	SENT_34	[p3l619t2585r1026b2686],
14	those	DT	O	those	prep_including	1	SENT_34	[p3l1063t2585r1291b2664],
15	from	IN	O	from	_	0	SENT_34	[p3l1331t2584r1538b2664],
16	patients	NNS	O	patient	prep_from	14	SENT_34	[p3l1577t2586r1911b2685],
17	who	WP	O	who	nsubj	18	SENT_34	[p3l1949t2585r2133b2664],
18	had	VBD	O	have	rcmod	16	SENT_34	[p3l10t2713r165b2791],
19	a	DT	O	a	det	20	SENT_34	[p3l186t2739r230b2790],
20	response	NN	O	response	dobj	18	SENT_34	[p3l250t2738r629b2812],
21	to	TO	O	to	_	0	SENT_34	[p3l651t2729r730b2791],
22	cetuximab	NN	O	cetuximab	prep_to	20	SENT_34	[p3l754t2713r1213b2808],
23	,	,	O	,	_	0	SENT_34	[p3l754t2713r1213b2808],
24	supports	VBZ	O	support	_	0	SENT_34	[p3l1241t2729r1609b2812],
25	the	DT	O	the	det	26	SENT_34	[p3l1633t2713r1763b2790],
26	speculation	NN	O	speculation	dobj	24	SENT_34	[p3l1786t2713r2133b2812, p3l11t2842r176b2919],
27	by	IN	O	by	_	0	SENT_34	[p3l212t2841r308b2940],
28	Barber	NNP	PERSON	Barber	prep_by	24	SENT_34	[p3l337t2841r620b2919],
29	et	FW	O	et	nn	30	SENT_34	[p3l653t2857r730b2918],
30	al.	FW	O	al.	dep	28	SENT_34	[p3l758t2841r899b2919],
31	4	CD	NUMBER	4	dep	30	SENT_34	[p3l758t2841r899b2919],
32	that	WDT	O	that	dobj	37	SENT_34	[p3l933t2841r1100b2918],
33	EGFR	NN	ORGANIZATION	egfr	nn	34	SENT_34	[p3l1128t2847r1340b2920],
34	mutations	NNS	O	mutation	nsubjpass	37	SENT_34	[p3l1368t2842r1799b2920],
35	are	VBP	O	be	auxpass	37	SENT_34	[p3l1835t2867r1960b2918],
36	not	RB	O	not	neg	37	SENT_34	[p3l1996t2857r2139b2919],
37	required	VBN	O	require	dep	24	SENT_34	[p3l10t2969r365b3069],
38	for	IN	O	for	_	0	SENT_34	[p3l392t2968r515b3048],
39	the	DT	O	the	det	40	SENT_34	[p3l540t2969r669b3047],
40	efﬁcacy	NN	O	efﬁcacy	prep_for	37	SENT_34	[p3l697t2968r1016b3069],
41	of	IN	O	of	_	0	SENT_34	[p3l1039t2968r1140b3048],
42	cetuximab	NN	O	cetuximab	prep_of	40	SENT_34	[p3l1149t2969r1583b3048],
43	in	IN	O	in	_	0	SENT_34	[p3l1611t2970r1693b3046],
44	colorectal	JJ	O	colorectal	amod	45	SENT_34	[p3l1721t2969r2134b3048],
45	cancer	NN	O	cancer	prep_in	37	SENT_34	[p3l11t3123r302b3175],
46	.	.	O	.	_	0	SENT_34	[p3l11t3123r302b3175],

1	(	NN	O	(	nsubjpass	7	SENT_35	[p3l345t3103r610b3188],
2	Some	DT	O	some	dep	1	SENT_35	[p3l345t3103r610b3188],
3	of	IN	O	of	_	0	SENT_35	[p3l644t3096r744b3176],
4	the	DT	O	the	det	5	SENT_35	[p3l759t3097r888b3175],
5	samples	NNS	O	sample	prep_of	1	SENT_35	[p3l923t3097r1265b3197],
6	were	VBD	O	be	auxpass	7	SENT_35	[p3l1295t3123r1497b3176],
7	chosen	VBN	O	choose	_	0	SENT_35	[p3l1531t3097r1829b3176],
8	for	IN	O	for	_	0	SENT_35	[p3l1862t3096r1985b3176],
9	sequence	NN	O	sequence	nn	10	SENT_35	[p3l2016t3123r2133b3175, p3l11t3251r309b3325],
10	analysis	NN	O	analysis	prep_for	7	SENT_35	[p3l361t3225r692b3325],
11	on	IN	O	on	_	0	SENT_35	[p3l747t3251r853b3304],
12	the	DT	O	the	det	13	SENT_35	[p3l906t3225r1035b3303],
13	basis	NN	O	basis	prep_on	7	SENT_35	[p3l1088t3225r1297b3304],
14	of	IN	O	of	_	0	SENT_35	[p3l1352t3224r1453b3304],
15	the	DT	O	the	det	17	SENT_35	[p3l1486t3225r1616b3303],
16	clinical	JJ	O	clinical	amod	17	SENT_35	[p3l1669t3225r1969b3303],
17	response	NN	O	response	prep_of	13	SENT_35	[p3l2021t3251r2133b3303, p3l12t3378r330b3452],
18	,	,	O	,	_	0	SENT_35	[p3l2021t3251r2133b3303, p3l12t3378r330b3452],
19	and	CC	O	and	_	0	SENT_35	[p3l365t3353r522b3431],
20	thus	RB	O	thus	advmod	30	SENT_35	[p3l552t3353r732b3432],
21	the	DT	O	the	det	22	SENT_35	[p3l766t3353r895b3430],
22	numbers	NNS	O	number	nsubj	30	SENT_35	[p3l926t3353r1301b3432],
23	We	PRP	O	we	nsubj	24	SENT_35	[p3l1330t3379r1448b3432],
24	mention	VBP	O	mention	rcmod	22	SENT_35	[p3l1480t3354r1836b3431],
25	in	IN	O	in	_	0	SENT_35	[p3l1867t3354r1948b3429],
26	this	DT	O	this	det	27	SENT_35	[p3l1979t3353r2132b3430],
27	letter	NN	O	letter	prep_in	24	SENT_35	[p3l9t3481r228b3559],
28	do	VBP	O	do	aux	30	SENT_35	[p3l249t3481r352b3560],
29	not	RB	O	not	neg	30	SENT_35	[p3l377t3498r520b3560],
30	reﬂect	VB	O	reﬂect	conj_and	7	SENT_35	[p3l538t3480r805b3559],
31	the	DT	O	the	det	33	SENT_35	[p3l824t3481r953b3559],
32	response	NN	O	response	nn	33	SENT_35	[p3l977t3507r1356b3581],
33	rates	NNS	O	rate	dobj	30	SENT_35	[p3l1379t3498r1578b3559],
34	in	IN	O	in	prep	33	SENT_35	[p3l1602t3482r1684b3558],
35	the	DT	O	the	det	36	SENT_35	[p3l1708t3481r1837b3559],
36	trials	NNS	O	trial	dep	34	SENT_35	[p3l1861t3481r2129b3572],
37	.	.	O	.	_	0	SENT_35	[p3l1861t3481r2129b3572],
38	)	SYM	O	)	dep	33	SENT_35	[p3l1861t3481r2129b3572],

1	In	IN	O	in	_	0	SENT_36	[p3l8t3617r96b3686],
2	addition	NN	O	addition	prep_in	5	SENT_36	[p3l129t3609r505b3705],
3	,	,	O	,	_	0	SENT_36	[p3l129t3609r505b3705],
4	We	PRP	O	we	nsubj	36	SENT_36	[p3l541t3635r659b3689],
5	sequenced	VBD	O	sequence	_	0	SENT_36	[p3l696t3609r1138b3709],
6	160	CD	NUMBER	160	num	8	SENT_36	[p3l1176t3615r1326b3688],
7	biopsy	NN	O	biopsy	nn	8	SENT_36	[p3l1362t3609r1640b3709],
8	samples	NNS	O	sample	dobj	5	SENT_36	[p3l1672t3609r2014b3709],
9	of	IN	O	of	_	0	SENT_36	[p3l2052t3608r2152b3688],
10	previously	RB	DATE	previously	advmod	11	SENT_36	[p4l8t21r443b120],
11	untreated	JJ	O	untreated	amod	14	SENT_36	[p4l460t21r862b100],
12	colorectal	JJ	O	colorectal	amod	14	SENT_36	[p4l884t21r1298b99],
13	cancer	NN	O	cancer	nn	14	SENT_36	[p4l1320t46r1595b98],
14	(	NN	O	(	prep_of	8	SENT_36	[p4l1619t21r2019b120],
15	provided	VBN	O	provide	prep	5	SENT_36	[p4l1619t21r2019b120],
16	by	IN	O	by	pcomp	15	SENT_36	[p4l2041t21r2138b120],
17	Dr.	NNP	O	Dr.	nn	19	SENT_36	[p4l8t155r134b227],
18	Sina	NNP	PERSON	Sina	nn	19	SENT_36	[p4l171t150r350b227],
19	Dorudi	NNP	PERSON	Dorudi	pobj	16	SENT_36	[p4l376t149r698b244],
20	,	,	O	,	_	0	SENT_36	[p4l376t149r698b244],
21	Royal	NNP	ORGANIZATION	Royal	nn	23	SENT_36	[p4l731t149r966b248],
22	London	NNP	ORGANIZATION	London	nn	23	SENT_36	[p4l993t149r1322b227],
23	Hospital	NNP	ORGANIZATION	Hospital	appos	19	SENT_36	[p4l1351t149r1737b248],
24	,	,	O	,	_	0	SENT_36	[p4l1351t149r1737b248],
25	London	NNP	LOCATION	London	appos	23	SENT_36	[p4l1771t149r2129b239],
26	)	CD	NUMBER	)	num	25	SENT_36	[p4l1771t149r2129b239],
27	from	IN	O	from	_	0	SENT_36	[p4l10t276r217b356],
28	patients	NNS	O	patient	prep_from	25	SENT_36	[p4l238t278r572b377],
29	outside	IN	O	outside	_	0	SENT_36	[p4l597t277r905b356],
30	the	DT	O	the	det	32	SENT_36	[p4l927t277r1056b355],
31	cetuximab	JJ	O	cetuximab	amod	32	SENT_36	[p4l1079t277r1513b356],
32	trial	NN	O	trial	prep_outside	28	SENT_36	[p4l1537t277r1703b355],
33	and	CC	O	and	_	0	SENT_36	[p4l1724t277r1880b356],
34	could	MD	O	could	aux	36	SENT_36	[p4l1902t277r2134b356],
35	not	RB	O	not	neg	36	SENT_36	[p4l10t422r153b483],
36	identify	VB	O	identify	conj_and	5	SENT_36	[p4l177t404r499b505],
37	any	DT	O	any	det	38	SENT_36	[p4l524t431r671b505],
38	mutation	NN	O	mutation	dobj	36	SENT_36	[p4l697t406r1086b484],
39	in	IN	O	in	_	0	SENT_36	[p4l1115t406r1196b482],
40	exons	NNS	O	exon	prep_in	36	SENT_36	[p4l1227t431r1467b484],
41	18	CD	NUMBER	18	dep	40	SENT_36	[p4l1503t411r1624b501],
42	,	,	O	,	_	0	SENT_36	[p4l1503t411r1624b501],
43	19	CD	NUMBER	19	num	41	SENT_36	[p4l1663t411r1783b501],
44	,	,	O	,	_	0	SENT_36	[p4l1663t411r1783b501],
45	and	CC	NUMBER	and	_	0	SENT_36	[p4l1819t405r1974b484],
46	21	CD	NUMBER	21	conj_and	41	SENT_36	[p4l2004t411r2129b483],
47	.	.	O	.	_	0	SENT_36	[p4l2004t411r2129b483],

1	This	DT	O	this	det	3	SENT_37	[p4l7t533r192b611],
2	further	JJ	O	further	amod	3	SENT_37	[p4l222t532r518b612],
3	conﬁrms	NNS	O	conﬁrms	_	0	SENT_37	[p4l545t532r923b612],
4	the	DT	O	the	det	6	SENT_37	[p4l955t533r1084b611],
5	general	JJ	O	general	amod	6	SENT_37	[p4l1113t533r1425b634],
6	absence	NN	O	absence	dep	3	SENT_37	[p4l1453t533r1788b612],
7	of	IN	O	of	_	0	SENT_37	[p4l1818t532r1919b612],
8	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_37	[p4l1927t540r2140b612],
9	mutations	NNS	O	mutation	prep_of	6	SENT_37	[p4l10t662r440b740],
10	in	IN	O	in	_	0	SENT_37	[p4l465t662r546b738],
11	colorectal	JJ	O	colorectal	amod	12	SENT_37	[p4l569t661r983b740],
12	cancer	NN	O	cancer	prep_in	9	SENT_37	[p4l1006t687r1297b740],
13	.	.	O	.	_	0	SENT_37	[p4l1006t687r1297b740],

1	Our	PRP$	O	we	poss	2	SENT_38	[p4l1325t666r1489b740],
2	results	NNS	O	result	nsubj	3	SENT_38	[p4l1509t661r1787b740],
3	suggest	VBP	O	suggest	_	0	SENT_38	[p4l1813t678r2139b762],

1	x6	NN	O	x6	nn	4	SENT_39	[p4l149t837r205b858],
2	*	CD	NUMBER	*	num	4	SENT_39	[p4l149t837r205b858],
3	N	NN	O	n	nn	4	SENT_39	[p4l919t839r933b854],
4	ENGLJ	NN	O	englj	_	0	SENT_39	[p4l948t838r1032b860],
5	MED	NN	O	med	dep	4	SENT_39	[p4l1047t839r1100b854],
6	<	JJR	O	<	amod	7	SENT_39	[p4l1112t838r1137b860],
7	g	NN	O	g	dep	5	SENT_39	[p4l1112t838r1137b860],
8	*	CD	NUMBER	*	num	10	SENT_39	[p4l1112t838r1137b860],
9	I2	NN	O	i2	nn	10	SENT_39	[p4l1156t838r1176b858],
10	WWW	NN	O	www	dep	5	SENT_39	[p4l1211t839r1323b854],
11	.	.	O	.	_	0	SENT_39	[p4l1211t839r1323b854],

1	NE	NNS	O	ne	nsubj	2	SENT_40	[p4l1211t839r1323b854],
2	M.ORG	VBP	O	m.org	_	0	SENT_40	[p4l1339t838r1422b854],
3	JULY14	NN	O	july14	dobj	2	SENT_40	[p4l1456t838r1563b860],
4	,	,	O	,	_	0	SENT_40	[p4l1456t838r1563b860],
5	2005	CD	DATE	2005	appos	3	SENT_40	[p4l1576t838r1639b860],

1	The	DT	O	the	det	5	SENT_41	[p4l936t871r987b895],
2	New	NNP	O	New	nn	5	SENT_41	[p4l996t872r1058b895],
3	Englan	NNP	O	Englan	nn	5	SENT_41	[p4l1067t871r1161b902],
4	oumal	NN	O	oumal	nn	5	SENT_41	[p4l1201t871r1284b895],
5	o	NN	O	o	_	0	SENT_41	[p4l1294t879r1309b895],
6	edicine	NN	O	edicine	dep	5	SENT_41	[p4l1360t871r1455b895],

1	Downloaded	VBN	O	download	_	0	SENT_42	[p4l378t912r548b935],
2	from	IN	O	from	_	0	SENT_42	[p4l557t912r621b935],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_42	[p4l630t912r748b942],
4	at	IN	O	at	_	0	SENT_42	[p4l759t916r782b935],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_42	[p4l790t912r973b935],
6	on	IN	O	on	_	0	SENT_42	[p4l982t919r1015b935],
7	Janu	NNP	DATE	Janu	prep_on	1	SENT_42	[p4l1023t912r1084b935],
8	5	CD	DATE	5	num	7	SENT_42	[p4l1136t912r1159b939],
9	,	,	DATE	,	_	0	SENT_42	[p4l1136t912r1159b939],
10	2014	CD	DATE	2014	num	7	SENT_42	[p4l1169t912r1242b935],
11	.	.	O	.	_	0	SENT_42	[p4l1169t912r1242b935],

1	For	IN	O	for	_	0	SENT_43	[p4l1252t912r1299b935],
2	personal	JJ	O	personal	amod	3	SENT_43	[p4l1307t912r1419b942],
3	use	NN	O	use	pobj	1	SENT_43	[p4l1428t919r1472b935],
4	only	RB	O	only	advmod	3	SENT_43	[p4l1482t912r1546b942],
5	.	.	O	.	_	0	SENT_43	[p4l1482t912r1546b942],

1	No	DT	O	no	det	3	SENT_44	[p4l1557t912r1597b935],
2	other	JJ	O	other	amod	3	SENT_44	[p4l1607t912r1675b935],
3	uses	NNS	O	use	_	0	SENT_44	[p4l1683t919r1739b935],
4	without	IN	O	without	_	0	SENT_44	[p4l1749t912r1850b935],
5	permission	NN	O	permission	prep_without	3	SENT_44	[p4l1859t912r2011b942],
6	.	.	O	.	_	0	SENT_44	[p4l1859t912r2011b942],

1	Copyright	NN	O	copyright	nsubj	6	SENT_45	[p4l728t953r863b984],
2	©	CD	NUMBER	©	num	1	SENT_45	[p4l872t953r896b977],
3	2005	CD	DATE	2005	num	5	SENT_45	[p4l906t953r970b977],
4	Massa	NNP	PERSON	Massa	nn	5	SENT_45	[p4l980t954r1065b977],
5	u	NN	O	u	dep	1	SENT_45	[p4l1097t961r1113b977],
6	etts	VBZ	O	ett	_	0	SENT_45	[p4l1127t957r1171b977],
7	Medical	NNP	ORGANIZATION	Medical	nn	8	SENT_45	[p4l1181t953r1289b977],
8	Society	NNP	ORGANIZATION	Society	dobj	6	SENT_45	[p4l1300t953r1405b984],
9	.	.	O	.	_	0	SENT_45	[p4l1300t953r1405b984],

1	All	DT	O	all	det	2	SENT_46	[p4l1416t953r1457b977],
2	rights	NNS	O	rights	nsubj	3	SENT_46	[p4l1466t953r1541b984],
3	reserved	VBN	O	reserve	_	0	SENT_46	[p4l1551t953r1670b977],
4	.	.	O	.	_	0	SENT_46	[p4l1551t953r1670b977],

1	CORRESPONDENCE	NN	O	correspondence	_	0	SENT_47	[p4l918t1059r1241b1078],

1	that	IN	O	that	dep	2	SENT_48	[p4l8t1273r176b1353],
2	in	IN	O	in	ccomp	24	SENT_48	[p4l192t1274r274b1352],
3	contrast	NN	O	contrast	pobj	2	SENT_48	[p4l296t1290r645b1353],
4	to	TO	O	to	_	0	SENT_48	[p4l662t1290r741b1353],
5	the	DT	O	the	det	6	SENT_48	[p4l764t1273r895b1353],
6	correlation	NN	O	correlation	prep_to	2	SENT_48	[p4l917t1274r1381b1353],
7	of	IN	O	of	_	0	SENT_48	[p4l1403t1273r1504b1353],
8	mutations	NNS	O	mutation	prep_of	6	SENT_48	[p4l1507t1274r1941b1354],
9	with	IN	O	with	_	0	SENT_48	[p4l1960t1273r2151b1354],
10	responses	NNS	O	response	prep_with	8	SENT_48	[p4l8t1426r432b1502],
11	to	TO	O	to	_	0	SENT_48	[p4l476t1417r555b1480],
12	the	DT	O	the	det	16	SENT_48	[p4l599t1400r728b1480],
13	EGFR	NN	ORGANIZATION	egfr	nn	16	SENT_48	[p4l768t1408r983b1481],
14	kinase	NN	O	kinase	nn	16	SENT_48	[p4l1017t1400r1290b1481],
15	inhibitors	NNS	O	inhibitor	nn	16	SENT_48	[p4l1330t1401r1748b1480],
16	geﬁtinib	NN	O	geﬁtinib	prep_to	2	SENT_48	[p4l1791t1400r2149b1502],
17	and	CC	O	and	_	0	SENT_48	[p4l7t1527r165b1605],
18	erlotinib	NN	O	erlotinib	conj_and	16	SENT_48	[p4l205t1527r591b1622],
19	,	,	O	,	_	0	SENT_48	[p4l205t1527r591b1622],
20	EGFR	NN	ORGANIZATION	egfr	nn	21	SENT_48	[p4l634t1533r849b1607],
21	mutations	NNS	O	mutation	nsubj	24	SENT_48	[p4l882t1527r1316b1606],
22	are	VBP	O	be	cop	24	SENT_48	[p4l1357t1553r1484b1605],
23	not	RB	O	not	neg	24	SENT_48	[p4l1524t1543r1669b1605],
24	critical	JJ	O	critical	_	0	SENT_48	[p4l1704t1526r1990b1605],
25	for	IN	O	for	_	0	SENT_48	[p4l2029t1526r2153b1605],
26	the	DT	O	the	det	27	SENT_48	[p4l8t1653r139b1733],
27	response	NN	O	response	prep_for	24	SENT_48	[p4l164t1679r546b1755],
28	of	IN	O	of	_	0	SENT_48	[p4l573t1653r674b1733],
29	a	DT	O	a	det	30	SENT_48	[p4l680t1680r724b1733],
30	tumor	NN	O	tumor	prep_of	27	SENT_48	[p4l749t1670r1014b1734],
31	to	TO	O	to	_	0	SENT_48	[p4l1036t1670r1116b1733],
32	cetuximab	NN	O	cetuximab	prep_to	24	SENT_48	[p4l1143t1654r1607b1734],
33	.	.	O	.	_	0	SENT_48	[p4l1143t1654r1607b1734],

1	Zenta	NNP	PERSON	Zenta	nn	2	SENT_49	[p4l9t1787r258b1860],
2	Tsuchihashi	NNP	PERSON	Tsuchihashi	_	0	SENT_49	[p4l290t1779r839b1874],
3	,	,	O	,	_	0	SENT_49	[p4l290t1779r839b1874],
4	Ph.D.	NNP	O	Ph.D.	appos	2	SENT_49	[p4l884t1779r1115b1860],
5	.	.	O	.	_	0	SENT_49	[p4l884t1779r1115b1860],

1	Shirin	NNP	PERSON	Shirin	nn	2	SENT_50	[p4l10t1906r261b1987],
2	Khambata-Ford	NNP	PERSON	Khambata-Ford	_	0	SENT_50	[p4l306t1906r1006b2001],
3	,	,	O	,	_	0	SENT_50	[p4l306t1906r1006b2001],
4	Ph.D.	NNP	O	Ph.D.	appos	2	SENT_50	[p4l1052t1906r1282b1987],
5	.	.	O	.	_	0	SENT_50	[p4l1052t1906r1282b1987],

1	Bristol-Myers	NNP	O	Bristol-Myers	nn	2	SENT_51	[p4l13t2070r448b2151],
2	Squibb	NNP	PERSON	Squibb	_	0	SENT_51	[p4l476t2070r705b2150],
3	Princeton	NNP	PERSON	Princeton	nn	7	SENT_51	[p4l13t2173r343b2239],
4	,	,	O	,	_	0	SENT_51	[p4l13t2173r343b2239],
5	NJ	NNP	O	NJ	appos	7	SENT_51	[p4l377t2173r446b2245],
6	08543-5400	CD	NUMBER	08543-5400	num	7	SENT_51	[p4l476t2171r861b2229],
7	zenta.tsuchihashi@bms.com	NNP	O	zenta.tsuchihashi@bms.com	dep	2	SENT_51	[p4l7t2246r988b2320],

1	Nasser	NNP	PERSON	Nasser	nn	2	SENT_52	[p4l16t2393r322b2466],
2	Hanna	NNP	PERSON	Hanna	_	0	SENT_52	[p4l360t2393r672b2481],
3	,	,	O	,	_	0	SENT_52	[p4l360t2393r672b2481],
4	M.D.	NNP	O	M.D.	appos	2	SENT_52	[p4l717t2393r925b2466],

1	Indiana	NNP	ORGANIZATION	Indiana	nn	3	SENT_53	[p4l13t2550r255b2611],
2	University	NNP	ORGANIZATION	University	nn	3	SENT_53	[p4l285t2555r615b2629],
3	Indianapolis	NNP	ORGANIZATION	Indianapolis	_	0	SENT_53	[p4l13t2629r437b2708],
4	,	,	O	,	_	0	SENT_53	[p4l13t2629r437b2708],
5	IN	IN	O	in	dep	3	SENT_53	[p4l470t2634r540b2689],
6	46202	CD	NUMBER	46202	num	9	SENT_53	[p4l569t2633r766b2690],
7	Pasi	NNP	PERSON	Pasi	nn	9	SENT_53	[p4l16t2776r184b2849],
8	A.	NN	PERSON	a.	nn	9	SENT_53	[p4l218t2773r606b2872],
9	J'anne	NNP	PERSON	J'anne	pobj	5	SENT_53	[p4l218t2773r606b2872],
10	,	,	O	,	_	0	SENT_53	[p4l218t2773r606b2872],
11	M.D.	NNP	O	M.D.	nn	13	SENT_53	[p4l651t2776r885b2863],
12	,	,	O	,	_	0	SENT_53	[p4l651t2776r885b2863],
13	Ph.D.	NNP	O	Ph.D.	appos	9	SENT_53	[p4l931t2768r1161b2849],
14	.	.	O	.	_	0	SENT_53	[p4l931t2768r1161b2849],

1	Dana	NNP	PERSON	Dana	_	0	SENT_54	[p4l13t2932r436b2993],
2	.	.	O	.	_	0	SENT_54	[p4l13t2932r436b2993],

1	—	NN	O	—	_	0	SENT_55	[p4l13t2932r436b2993],
2	.	.	O	.	_	0	SENT_55	[p4l13t2932r436b2993],

1	Farber	NNP	ORGANIZATION	Farber	nn	4	SENT_56	[p4l13t2932r436b2993],
2	Cancer	NNP	ORGANIZATION	Cancer	nn	4	SENT_56	[p4l459t2937r686b2993],
3	Institute	NNP	ORGANIZATION	Institute	nn	4	SENT_56	[p4l714t2937r986b2993],
4	Boston	NNP	ORGANIZATION	Boston	_	0	SENT_56	[p4l13t3034r260b3098],
5	,	,	O	,	_	0	SENT_56	[p4l13t3034r260b3098],
6	MA	NNP	O	MA	appos	4	SENT_56	[p4l293t3032r404b3088],
7	02115	CD	DATE	02115	num	6	SENT_56	[p4l426t3032r620b3089],

1	Dr.	NNP	O	Dr.	nn	2	SENT_57	[p4l95t3131r190b3186],
2	Hanna	NNP	PERSON	Hanna	nsubj	3	SENT_57	[p4l223t3132r437b3186],
3	reports	VBZ	O	report	_	0	SENT_57	[p4l465t3139r691b3202],
4	having	VBG	O	have	aux	5	SENT_57	[p4l722t3126r938b3203],
5	received	VBN	O	receive	xcomp	3	SENT_57	[p4l965t3126r1223b3186],
6	grant	NN	O	grant	nn	7	SENT_57	[p4l1252t3139r1424b3203],
7	support	NN	O	support	dobj	5	SENT_57	[p4l1451t3139r1702b3202],
8	from	IN	O	from	_	0	SENT_57	[p4l1727t3126r1884b3186],
9	BristolMyers	NNPS	O	BristolMyers	nn	10	SENT_57	[p4l1912t3126r2148b3186, p4l7t3229r198b3300],
10	Squibb	NNP	O	Squibb	prep_from	5	SENT_57	[p4l220t3223r459b3300],
11	.	.	O	.	_	0	SENT_57	[p4l220t3223r459b3300],

1	Dr.	NNP	O	Dr.	nn	2	SENT_58	[p4l481t3228r576b3283],
2	Janne	NNP	PERSON	Janne	nsubj	3	SENT_58	[p4l590t3228r774b3292],
3	reports	VBZ	O	report	_	0	SENT_58	[p4l793t3236r1018b3300],
4	having	VBG	O	have	aux	5	SENT_58	[p4l1039t3223r1255b3300],
5	received	VBN	O	receive	dep	3	SENT_58	[p4l1270t3223r1528b3283],
6	an	DT	O	a	det	8	SENT_58	[p4l1546t3243r1622b3283],
7	unrestricted	JJ	O	unrestricted	amod	8	SENT_58	[p4l1640t3223r2024b3283],
8	gift	NN	O	gift	dobj	5	SENT_58	[p4l2042t3223r2153b3300],
9	from	IN	O	from	_	0	SENT_58	[p4l9t3320r166b3380],
10	Genentech	NNP	ORGANIZATION	Genentech	prep_from	5	SENT_58	[p4l189t3320r534b3380],
11	and	CC	O	and	_	0	SENT_58	[p4l556t3320r674b3380],
12	being	VBG	O	be	cop	14	SENT_58	[p4l696t3321r877b3397],
13	a	DT	O	a	det	14	SENT_58	[p4l896t3341r930b3380],
14	participant	NN	O	participant	conj_and	5	SENT_58	[p4l950t3321r1302b3397],
15	in	IN	O	in	_	0	SENT_58	[p4l1319t3321r1381b3379],
16	a	DT	O	a	det	18	SENT_58	[p4l1403t3341r1436b3380],
17	patent	NN	O	patent	nn	18	SENT_58	[p4l1457t3333r1661b3397],
18	application	NN	O	application	prep_in	14	SENT_58	[p4l1679t3321r2036b3397],
19	for	IN	O	for	_	0	SENT_58	[p4l2059t3320r2152b3380],
20	EGFR	NN	ORGANIZATION	egfr	nn	22	SENT_58	[p4l8t3421r168b3477],
21	mutation	NN	O	mutation	nn	22	SENT_58	[p4l182t3417r476b3476],
22	detection	NN	O	detection	prep_for	18	SENT_58	[p4l496t3416r807b3476],
23	.	.	O	.	_	0	SENT_58	[p4l496t3416r807b3476],

1	1	LS	NUMBER	1	_	0	SENT_59	[p4l12t3575r60b3627],
2	.	.	O	.	_	0	SENT_59	[p4l12t3575r60b3627],

1	Paez	NNP	PERSON	Paez	nn	2	SENT_60	[p4l138t3572r282b3626],
2	JG	NNP	O	JG	_	0	SENT_60	[p4l293t3571r395b3639],
3	,	,	O	,	_	0	SENT_60	[p4l293t3571r395b3639],
4	Janne	NNP	PERSON	Janne	nn	5	SENT_60	[p4l410t3572r594b3636],
5	PA	NN	PERSON	pa	appos	2	SENT_60	[p4l611t3572r711b3640],
6	,	,	O	,	_	0	SENT_60	[p4l611t3572r711b3640],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_60	[p4l732t3572r839b3626],
8	JC	NNP	PERSON	JC	appos	2	SENT_60	[p4l850t3571r943b3640],
9	,	,	O	,	_	0	SENT_60	[p4l850t3571r943b3640],
10	et	FW	O	et	nn	11	SENT_60	[p4l966t3580r1024b3626],
11	al.	FW	O	al.	appos	2	SENT_60	[p4l1038t3567r1109b3627],
12	.	.	O	.	_	0	SENT_60	[p4l1038t3567r1109b3627],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_61	[p4l1130t3571r1326b3630],
2	mutations	NNS	O	mutation	_	0	SENT_61	[p4l1336t3568r1661b3627],
3	in	IN	O	in	_	0	SENT_61	[p4l1680t3568r1741b3626],
4	lung	NN	O	lung	nn	5	SENT_61	[p4l1758t3567r1905b3644],
5	cancer	NN	O	cancer	prep_in	2	SENT_61	[p4l1921t3586r2145b3627],
6	:	:	O	:	_	0	SENT_61	[p4l1921t3586r2145b3627],
7	correlation	NN	O	correlation	dep	2	SENT_61	[p4l10t3663r358b3723],
8	with	IN	O	with	_	0	SENT_61	[p4l372t3663r515b3723],
9	clinical	JJ	O	clinical	amod	10	SENT_61	[p4l533t3663r760b3722],
10	response	NN	O	response	prep_with	7	SENT_61	[p4l777t3683r1064b3739],
11	to	TO	O	to	_	0	SENT_61	[p4l1082t3676r1141b3723],
12	geﬁtinib	NN	O	geﬁtinib	nn	13	SENT_61	[p4l1160t3663r1427b3740],
13	therapy	NN	O	therapy	prep_to	10	SENT_61	[p4l1447t3663r1693b3739],
14	.	.	O	.	_	0	SENT_61	[p4l1447t3663r1693b3739],

1	Science	NNP	O	Science	_	0	SENT_62	[p4l1717t3664r1952b3723],
2	2004	CD	DATE	2004	num	1	SENT_62	[p4l1970t3667r2145b3735],
3	;	:	O	;	_	0	SENT_62	[p4l1970t3667r2145b3735],

1	304:1497	CD	NUMBER	304:1497	_	0	SENT_63	[p5l10t19r472b75],
2	—	CD	NUMBER	—	number	3	SENT_63	[p5l10t19r472b75],
3	500	CD	NUMBER	500	num	1	SENT_63	[p5l10t19r472b75],
4	.	.	O	.	_	0	SENT_63	[p5l10t19r472b75],

1	2	LS	NUMBER	2	_	0	SENT_64	[p5l8t120r60b172],
2	.	.	O	.	_	0	SENT_64	[p5l8t120r60b172],

1	Pao	NNP	O	Pao	nn	2	SENT_65	[p5l138t117r252b172],
2	W	NNP	O	W	_	0	SENT_65	[p5l266t117r345b184],
3	,	,	O	,	_	0	SENT_65	[p5l266t117r345b184],
4	Miller	NNP	PERSON	Miller	nn	5	SENT_65	[p5l363t112r556b171],
5	V	NNP	O	V	appos	2	SENT_65	[p5l567t117r620b185],
6	,	,	O	,	_	0	SENT_65	[p5l567t117r620b185],
7	Zakowski	NNP	O	Zakowski	nn	8	SENT_65	[p5l639t112r947b172],
8	M	NNP	O	M	appos	2	SENT_65	[p5l960t117r1042b185],
9	,	,	O	,	_	0	SENT_65	[p5l960t117r1042b185],
10	et	FW	O	et	nn	11	SENT_65	[p5l1063t125r1121b171],
11	al.	FW	O	al.	appos	2	SENT_65	[p5l1132t112r1204b172],
12	.	.	O	.	_	0	SENT_65	[p5l1132t112r1204b172],

1	EGF	NN	ORGANIZATION	egf	nn	4	SENT_66	[p5l1223t116r1360b172],
2	receptor	NN	O	receptor	nn	4	SENT_66	[p5l1377t125r1643b188],
3	gene	NN	O	gene	nn	4	SENT_66	[p5l1656t131r1807b189],
4	mutations	NNS	O	mutation	nsubjpass	17	SENT_66	[p5l1823t113r2147b172],
5	are	VBP	O	be	cop	6	SENT_66	[p5l9t228r105b267],
6	common	JJ	O	common	_	0	SENT_66	[p5l126t228r414b268],
7	in	IN	O	in	_	0	SENT_66	[p5l434t209r495b267],
8	lung	NN	O	lung	nn	9	SENT_66	[p5l516t208r663b285],
9	cancers	NNS	O	cancer	prep_in	6	SENT_66	[p5l682t228r919b267],
10	from	IN	O	from	_	0	SENT_66	[p5l942t208r1099b268],
11	“	CD	NUMBER	“	prep_from	9	SENT_66	[p5l1122t212r1327b268],
12	never	RB	O	never	advmod	9	SENT_66	[p5l1122t212r1327b268],
13	smokers	NNS	O	smoker	dep	9	SENT_66	[p5l1348t208r1651b268],
14	”	CD	NUMBER	”	tmod	6	SENT_66	[p5l1348t208r1651b268],
15	and	CC	O	and	_	0	SENT_66	[p5l1675t208r1792b268],
16	are	VBP	O	be	auxpass	17	SENT_66	[p5l1813t228r1909b267],
17	associated	VBN	O	associate	conj_and	6	SENT_66	[p5l1930t209r2149b268, p5l9t305r142b365],
18	With	IN	O	with	_	0	SENT_66	[p5l163t305r306b365],
19	sensitivity	NN	O	sensitivity	prep_with	17	SENT_66	[p5l331t306r649b381],
20	of	IN	O	of	_	0	SENT_66	[p5l670t305r746b365],
21	tumors	NNS	O	tumor	prep_of	19	SENT_66	[p5l757t318r985b365],
22	to	TO	O	to	_	0	SENT_66	[p5l1012t318r1072b365],
23	geﬁtinib	NN	O	geﬁtinib	prep_to	17	SENT_66	[p5l1096t305r1365b382],
24	and	CC	O	and	_	0	SENT_66	[p5l1390t305r1508b365],
25	erlotinib	NN	O	erlotinib	conj_and	23	SENT_66	[p5l1533t305r1822b365],
26	.	.	O	.	_	0	SENT_66	[p5l1533t305r1822b365],

1	Proc	NNP	O	Proc	nn	7	SENT_67	[p5l1850t310r1992b365],
2	Natl	NNP	O	Natl	nn	7	SENT_67	[p5l2014t305r2151b365],
3	Acad	NNP	O	Acad	nn	7	SENT_67	[p5l7t402r166b461],
4	Sci	NNP	O	Sci	nn	7	SENT_67	[p5l186t403r276b461],
5	U	NNP	O	U	nn	7	SENT_67	[p5l294t407r346b461],
6	S	NNP	O	S	nn	7	SENT_67	[p5l365t406r397b461],
7	A	NNP	O	A	_	0	SENT_67	[p5l416t407r465b460],
8	2004	CD	DATE	2004	num	7	SENT_67	[p5l482t406r1126b473],
9	;	:	O	;	_	0	SENT_67	[p5l482t406r1126b473],
10	101:13306	CD	NUMBER	101:13306	number	11	SENT_67	[p5l482t406r1126b473],
11	—	CD	NUMBER	—	dep	7	SENT_67	[p5l482t406r1126b473],
12	11	CD	NUMBER	11	dep	11	SENT_67	[p5l482t406r1126b473],
13	.	.	O	.	_	0	SENT_67	[p5l482t406r1126b473],

1	3	LS	NUMBER	3	_	0	SENT_68	[p5l9t506r60b559],
2	.	.	O	.	_	0	SENT_68	[p5l9t506r60b559],

1	Lynch	NNP	PERSON	Lynch	nn	3	SENT_69	[p5l138t499r329b575],
2	T	NN	O	t	nn	3	SENT_69	[p5l346t504r430b572],
3	]	NN	O	]	_	0	SENT_69	[p5l346t504r430b572],
4	,	,	O	,	_	0	SENT_69	[p5l346t504r430b572],
5	Bell	NNP	ORGANIZATION	Bell	nn	6	SENT_69	[p5l454t499r575b558],
6	DW	NNP	ORGANIZATION	DW	appos	3	SENT_69	[p5l593t504r724b571],
7	,	,	O	,	_	0	SENT_69	[p5l593t504r724b571],
8	Sordella	NNP	PERSON	Sordella	nn	9	SENT_69	[p5l749t499r1008b559],
9	R	NNP	PERSON	R	appos	3	SENT_69	[p5l1026t504r1090b572],
10	,	,	O	,	_	0	SENT_69	[p5l1026t504r1090b572],
11	et	FW	O	et	nn	12	SENT_69	[p5l1115t512r1173b558],
12	al.	FW	O	al.	appos	3	SENT_69	[p5l1188t499r1260b559],
13	.	.	O	.	_	0	SENT_69	[p5l1188t499r1260b559],

1	Activating	VBG	O	activate	amod	2	SENT_70	[p5l1281t500r1607b576],
2	mutations	NNS	O	mutation	_	0	SENT_70	[p5l1623t500r1948b559],
3	in	IN	O	in	_	0	SENT_70	[p5l1969t500r2031b558],
4	the	DT	O	the	det	7	SENT_70	[p5l2050t499r2148b558],
5	epidermal	JJ	O	epidermal	amod	7	SENT_70	[p5l10t595r328b671],
6	growth	NN	O	growth	nn	7	SENT_70	[p5l343t595r570b672],
7	factor	NN	O	factor	prep_in	2	SENT_70	[p5l586t595r770b655],
8	receptor	NN	O	receptor	nn	10	SENT_70	[p5l783t608r1046b671],
9	underlying	VBG	O	underlie	amod	10	SENT_70	[p5l1059t595r1403b672],
10	responsiveness	NN	O	responsiveness	dep	2	SENT_70	[p5l1416t596r1892b671],
11	of	IN	O	of	_	0	SENT_70	[p5l1910t595r1986b655],
12	nonsmall-cell	JJ	O	nonsmall-cell	amod	14	SENT_70	[p5l1988t615r2153b655, p5l11t692r319b751],
13	lung	NN	O	lung	nn	14	SENT_70	[p5l336t692r483b769],
14	cancer	NN	O	cancer	prep_of	10	SENT_70	[p5l499t712r707b751],
15	to	TO	O	to	_	0	SENT_70	[p5l723t705r783b752],
16	geﬁtinib	NN	O	geﬁtinib	prep_to	14	SENT_70	[p5l802t692r1089b769],
17	.	.	O	.	_	0	SENT_70	[p5l802t692r1089b769],

1	N	NN	O	n	nn	3	SENT_71	[p5l1110t698r1167b752],
2	Engll	NNP	O	Engll	nn	3	SENT_71	[p5l1183t692r1368b769],
3	Med	NNP	O	Med	_	0	SENT_71	[p5l1382t692r1523b752],
4	2004	CD	DATE	2004	num	3	SENT_71	[p5l1541t696r2145b764],
5	;	:	O	;	_	0	SENT_71	[p5l1541t696r2145b764],
6	350:2129	CD	NUMBER	350:2129	number	7	SENT_71	[p5l1541t696r2145b764],
7	-39	CD	NUMBER	-39	dep	3	SENT_71	[p5l1541t696r2145b764],
8	.	.	O	.	_	0	SENT_71	[p5l1541t696r2145b764],

1	4	LS	NUMBER	4	_	0	SENT_72	[p5l8t798r60b850],
2	.	.	O	.	_	0	SENT_72	[p5l8t798r60b850],

1	Barber	NNP	O	Barber	nn	2	SENT_73	[p5l138t790r352b850],
2	TD	NNP	O	TD	_	0	SENT_73	[p5l376t795r490b863],
3	,	,	O	,	_	0	SENT_73	[p5l376t795r490b863],
4	Vogelstein	NNP	PERSON	Vogelstein	nn	5	SENT_73	[p5l520t790r854b867],
5	B	NNP	PERSON	B	appos	2	SENT_73	[p5l881t795r942b862],
6	,	,	O	,	_	0	SENT_73	[p5l881t795r942b862],
7	Kinzler	NNP	PERSON	Kinzler	nn	8	SENT_73	[p5l974t790r1209b851],
8	KW	NNP	O	KW	appos	2	SENT_73	[p5l1235t795r1362b862],
9	,	,	O	,	_	0	SENT_73	[p5l1235t795r1362b862],
10	Velculescu	NNP	O	Velculescu	nn	11	SENT_73	[p5l1392t790r1728b850],
11	VE	NNP	O	VE	appos	2	SENT_73	[p5l1753t795r1859b850],
12	.	.	O	.	_	0	SENT_73	[p5l1753t795r1859b850],

1	Somatic	JJ	MISC	somatic	amod	2	SENT_74	[p5l1893t791r2149b850],
2	mutations	NNS	O	mutation	_	0	SENT_74	[p5l9t887r334b946],
3	of	IN	O	of	_	0	SENT_74	[p5l355t886r430b946],
4	EGFR	NN	ORGANIZATION	egfr	prep_of	2	SENT_74	[p5l433t891r593b946],
5	in	IN	O	in	_	0	SENT_74	[p5l605t887r667b945],
6	colorectal	JJ	O	colorectal	amod	7	SENT_74	[p5l685t886r997b946],
7	cancers	NNS	O	cancer	prep_in	2	SENT_74	[p5l1015t906r1252b945],
8	and	CC	O	and	_	0	SENT_74	[p5l1270t886r1388b946],
9	glioblastomas	NNS	O	glioblastoma	prep_in	2	SENT_74	[p5l1405t886r1874b963],
10	.	.	O	.	_	0	SENT_74	[p5l1405t886r1874b963],

1	N	NN	O	n	nn	2	SENT_75	[p5l1894t891r1951b946],
2	EnglJ	NN	O	englj	nsubj	3	SENT_75	[p5l1966t886r2151b963],
3	Med	VBD	O	med	_	0	SENT_75	[p5l7t983r149b1042],
4	2004	CD	DATE	2004	dobj	3	SENT_75	[p5l167t987r665b1054],
5	;	:	O	;	_	0	SENT_75	[p5l167t987r665b1054],
6	351:2883	CD	NUMBER	351:2883	dep	4	SENT_75	[p5l167t987r665b1054],
7	.	.	O	.	_	0	SENT_75	[p5l167t987r665b1054],

1	5	CD	NUMBER	5	_	0	SENT_76	[p5l10t1088r60b1140],
2	.	.	O	.	_	0	SENT_76	[p5l10t1088r60b1140],

1	N	NN	O	n	nn	3	SENT_77	[p5l138t1085r194b1140],
2	g	NN	O	g	nn	3	SENT_77	[p5l196t1100r237b1157],
3	M	NN	O	m	_	0	SENT_77	[p5l263t1085r346b1152],
4	,	,	O	,	_	0	SENT_77	[p5l263t1085r346b1152],
5	Cunningham	NNP	PERSON	Cunningham	nn	9	SENT_77	[p5l381t1080r806b1157],
6	D.	NNP	PERSON	D.	nn	9	SENT_77	[p5l835t1085r902b1140],
7	Cetuximab	NNP	PERSON	Cetuximab	nn	9	SENT_77	[p5l938t1080r1282b1140],
8	(	NNP	O	(	nn	9	SENT_77	[p5l1318t1080r1594b1149],
9	Erbitux	NNP	O	Erbitux	appos	3	SENT_77	[p5l1318t1080r1594b1149],
10	)	CD	NUMBER	)	number	11	SENT_77	[p5l1318t1080r1594b1149],
11	—	CD	NUMBER	—	dep	9	SENT_77	[p5l1626t1114r1708b1120],
12	an	DT	O	a	nsubj	14	SENT_77	[p5l1736t1099r1812b1139],
13	emerging	VBG	O	emerge	amod	12	SENT_77	[p5l1844t1081r2152b1157],
14	targeted	VBN	O	target	rcmod	3	SENT_77	[p5l10t1176r271b1253],
15	therapy	NN	O	therapy	dobj	14	SENT_77	[p5l302t1176r541b1252],
16	for	IN	O	for	_	0	SENT_77	[p5l568t1176r661b1236],
17	epidermal	JJ	O	epidermal	amod	21	SENT_77	[p5l690t1176r1011b1252],
18	growth	NN	O	growth	nn	21	SENT_77	[p5l1040t1176r1270b1253],
19	factor	NN	O	factor	nn	21	SENT_77	[p5l1300t1176r1486b1236],
20	receptor-expressing	JJ	O	receptor-expressing	amod	21	SENT_77	[p5l1514t1177r2152b1253],
21	tumours	NNS	O	tumour	prep_for	15	SENT_77	[p5l10t1286r298b1333],
22	.	.	O	.	_	0	SENT_77	[p5l10t1286r298b1333],

1	Int	NN	O	int	nn	4	SENT_78	[p5l320t1278r449b1342],
2	]	CD	NUMBER	]	num	4	SENT_78	[p5l320t1278r449b1342],
3	Clin	NNP	O	Clin	nn	4	SENT_78	[p5l466t1273r597b1333],
4	Pract	NNP	O	Pract	_	0	SENT_78	[p5l614t1278r778b1332],
5	2004	CD	DATE	2004	dep	4	SENT_78	[p5l793t1277r1277b1343],
6	;	:	O	;	_	0	SENT_78	[p5l793t1277r1277b1343],
7	58:970	CD	NUMBER	58:970	number	8	SENT_78	[p5l793t1277r1277b1343],
8	—	CD	NUMBER	—	dep	4	SENT_78	[p5l793t1277r1277b1343],
9	6	CD	NUMBER	6	dep	8	SENT_78	[p5l793t1277r1277b1343],
10	.	.	O	.	_	0	SENT_78	[p5l793t1277r1277b1343],

1	Lack	NN	O	lack	_	0	SENT_79	[p5l373t1419r488b1468],
2	of	IN	O	of	_	0	SENT_79	[p5l505t1418r565b1468],
3	Mutations	NNS	O	mutation	prep_of	1	SENT_79	[p5l577t1420r845b1468],
4	in	IN	O	in	dep	1	SENT_79	[p5l865t1420r909b1467],
5	EGFR	NN	ORGANIZATION	egfr	pobj	4	SENT_79	[p5l930t1423r1079b1468],
6	in	IN	O	in	dep	1	SENT_79	[p5l1097t1420r1140b1467],
7	Gastroenteropancreatic	JJ	LOCATION	gastroenteropancreatic	pobj	6	SENT_79	[p5l1161t1420r1787b1482],

1	Neuroendocrine	JJ	O	neuroendocrine	amod	2	SENT_80	[p5l758t1494r1186b1543],
2	Tumors	NNS	O	tumor	_	0	SENT_80	[p5l1202t1498r1399b1543],

1	TO	TO	O	to	aux	4	SENT_81	[p5l9t1743r110b1793],
2	TH	NN	O	th	nn	4	SENT_81	[p5l138t1744r237b1793],
3	E	NN	O	e	nn	4	SENT_81	[p5l256t1745r289b1793],
4	EDITOR	NN	O	editor	_	0	SENT_81	[p5l325t1743r629b1794],
5	:	:	O	:	_	0	SENT_81	[p5l325t1743r629b1794],
6	Lynch	NNP	PERSON	Lynch	dep	4	SENT_81	[p5l657t1715r916b1816],
7	et	FW	O	et	nn	8	SENT_81	[p5l943t1732r1021b1794],
8	al.	FW	O	al.	nsubj	15	SENT_81	[p5l1043t1715r1187b1794],
9	1	CD	NUMBER	1	dep	8	SENT_81	[p5l1043t1715r1187b1794],
10	and	CC	O	and	_	0	SENT_81	[p5l1213t1715r1372b1794],
11	Paez	NNP	PERSON	Paez	conj_and	8	SENT_81	[p5l1397t1722r1592b1794],
12	et	FW	O	et	nn	13	SENT_81	[p5l1620t1732r1698b1794],
13	al.	FW	O	al.	dep	11	SENT_81	[p5l1719t1715r1863b1794],
14	2	CD	NUMBER	2	dep	13	SENT_81	[p5l1719t1715r1863b1794],
15	correlated	VBD	O	correlate	rcmod	6	SENT_81	[p5l1891t1741r2145b1794, p5l10t1843r213b1922],
16	the	DT	O	the	det	17	SENT_81	[p5l238t1843r366b1922],
17	presence	NN	O	presence	dobj	15	SENT_81	[p5l390t1869r759b1944],
18	of	IN	O	of	_	0	SENT_81	[p5l786t1843r885b1922],
19	somatic	JJ	O	somatic	amod	20	SENT_81	[p5l894t1844r1220b1922],
20	mutations	NNS	O	mutation	prep_of	17	SENT_81	[p5l1245t1844r1670b1922],
21	in	IN	O	in	_	0	SENT_81	[p5l1697t1844r1778b1921],
22	the	DT	O	the	det	25	SENT_81	[p5l1804t1843r1931b1922],
23	tyrosine	NN	O	tyrosine	nn	25	SENT_81	[p5l1958t1860r2148b1944, p5l12t1972r178b2050],
24	kinase	NN	O	kinase	nn	25	SENT_81	[p5l210t1971r487b2051],
25	domain	NN	O	domain	prep_in	15	SENT_81	[p5l525t1971r856b2050],
26	of	IN	O	of	_	0	SENT_81	[p5l894t1971r995b2050],
27	the	DT	O	the	det	28	SENT_81	[p5l1014t1971r1146b2050],
28	gene	NN	O	gene	prep_of	25	SENT_81	[p5l1183t1997r1386b2072],
29	that	WDT	O	that	nsubj	30	SENT_81	[p5l1423t1971r1595b2050],
30	encodes	VBZ	O	encode	rcmod	28	SENT_81	[p5l1627t1971r1975b2050],
31	the	DT	O	the	det	38	SENT_81	[p5l2015t1971r2147b2050],
32	epidermal	JJ	O	epidermal	amod	38	SENT_81	[p5l11t2099r448b2200],
33	growth	NN	O	growth	nn	38	SENT_81	[p5l480t2099r790b2200],
34	factor	NN	O	factor	nn	38	SENT_81	[p5l823t2099r1076b2178],
35	receptor	NN	O	receptor	nn	38	SENT_81	[p5l1106t2116r1467b2200],
36	(	CD	NUMBER	(	num	38	SENT_81	[p5l1501t2106r1771b2191],
37	EGFR	NN	ORGANIZATION	egfr	nn	38	SENT_81	[p5l1501t2106r1771b2191],
38	)	NN	O	)	dobj	30	SENT_81	[p5l1501t2106r1771b2191],
39	with	IN	O	with	_	0	SENT_81	[p5l1805t2099r1999b2178],
40	responsiveness	NN	O	responsiveness	prep_with	38	SENT_81	[p5l2031t2126r2145b2178, p5l12t2228r581b2328],
41	to	TO	O	to	_	0	SENT_81	[p5l621t2244r702b2306],
42	geﬁtinib	NN	O	geﬁtinib	prep_to	4	SENT_81	[p5l741t2227r1107b2328],
43	in	IN	O	in	_	0	SENT_81	[p5l1145t2228r1228b2305],
44	non	JJ	O	non	amod	50	SENT_81	[p5l1266t2227r1916b2306],
45	—	JJ	O	—	amod	50	SENT_81	[p5l1266t2227r1916b2306],
46	small	JJ	O	small	amod	50	SENT_81	[p5l1266t2227r1916b2306],
47	—	NN	O	—	nn	50	SENT_81	[p5l1266t2227r1916b2306],
48	cell	NN	O	cell	nn	50	SENT_81	[p5l1266t2227r1916b2306],
49	lung	NN	O	lung	nn	50	SENT_81	[p5l1952t2227r2151b2328],
50	carcinoma	NN	O	carcinoma	prep_in	42	SENT_81	[p5l11t2356r471b2434],
51	.	.	O	.	_	0	SENT_81	[p5l11t2356r471b2434],

1	N	NN	O	n	nn	3	SENT_82	[p5l504t2363r580b2434],
2	euroendocrine	NN	O	euroendocrine	nn	3	SENT_82	[p5l582t2355r1187b2434],
3	differentiation	NN	O	differentiation	nsubj	5	SENT_82	[p5l1218t2355r1814b2434],
4	is	VBZ	O	be	cop	5	SENT_82	[p5l1844t2356r1908b2434],
5	present	JJ	DATE	present	dep	19	SENT_82	[p5l1939t2381r2148b2456, p5l11t2500r144b2562],
6	in	IN	O	in	_	0	SENT_82	[p5l173t2484r253b2561],
7	a	DT	O	a	det	9	SENT_82	[p5l290t2510r335b2562],
8	substantial	JJ	O	substantial	amod	9	SENT_82	[p5l375t2483r852b2562],
9	number	NN	O	number	prep_in	5	SENT_82	[p5l891t2483r1235b2562],
10	of	IN	O	of	_	0	SENT_82	[p5l1273t2483r1375b2562],
11	gastroenteropan	NN	O	gastroenteropan	nn	12	SENT_82	[p5l1396t2500r2145b2584],
12	—	NN	O	—	prep_of	9	SENT_82	[p5l1396t2500r2145b2584],
13	creatic	JJ	O	creatic	amod	15	SENT_82	[p5l11t2612r294b2690],
14	neuroendocrine	NN	O	neuroendocrine	nn	15	SENT_82	[p5l342t2611r1033b2691],
15	tumors,-3	NN	O	tumors,-3	dep	12	SENT_82	[p5l1082t2617r1463b2707],
16	and	CC	O	and	_	0	SENT_82	[p5l1513t2611r1672b2690],
17	EGFR	NN	ORGANIZATION	egfr	nn	18	SENT_82	[p5l1719t2617r1983b2695],
18	expression	NN	O	expression	dep	12	SENT_82	[p5l2022t2638r2145b2690, p5l10t2741r381b2841],
19	occurs	VBZ	O	occur	_	0	SENT_82	[p5l410t2766r689b2819],
20	in	IN	O	in	_	0	SENT_82	[p5l718t2741r801b2818],
21	such	JJ	O	such	amod	22	SENT_82	[p5l829t2740r1028b2819],
22	tumors	NNS	O	tumor	prep_in	19	SENT_82	[p5l1056t2746r1439b2819],
23	.4	CD	NUMBER	.4	nsubj	19	SENT_82	[p5l1056t2746r1439b2819],

1	We	PRP	O	we	nsubj	2	SENT_83	[p5l137t2876r271b2947],
2	sought	VBD	O	seek	_	0	SENT_83	[p5l308t2868r605b2969],
3	EGFR	NN	ORGANIZATION	egfr	dobj	2	SENT_83	[p5l634t2869r1330b2969],
4	—	CD	NUMBER	—	num	3	SENT_83	[p5l634t2869r1330b2969],
5	activating	VBG	O	activate	partmod	3	SENT_83	[p5l634t2869r1330b2969],
6	mutations	NNS	O	mutation	dobj	5	SENT_83	[p5l1363t2869r1796b2947],
7	in	IN	O	in	_	0	SENT_83	[p5l1833t2869r1915b2946],
8	a	DT	O	a	det	9	SENT_83	[p5l1950t2895r1995b2947],
9	series	NN	O	series	prep_in	5	SENT_83	[p5l2030t2895r2147b2947, p5l11t2997r156b3075],
10	of	IN	O	of	_	0	SENT_83	[p5l191t2996r291b3075],
11	rare	JJ	O	rare	amod	14	SENT_83	[p5l304t3022r464b3075],
12	gastroenteropancreatic	JJ	O	gastroenteropancreatic	amod	14	SENT_83	[p5l496t2997r1456b3097],
13	neuroendocrine	NN	O	neuroendocrine	nn	14	SENT_83	[p5l1487t2996r2149b3075],
14	cancers	NNS	O	cancer	prep_of	9	SENT_83	[p5l11t3150r345b3203],
15	.	.	O	.	_	0	SENT_83	[p5l11t3150r345b3203],

1	DNA	NN	O	dna	nsubj	8	SENT_84	[p5l373t3131r586b3203],
2	was	VBD	O	be	cop	8	SENT_84	[p5l604t3151r766b3204],
3	isolated	VBN	O	isolate	amod	8	SENT_84	[p5l793t3124r1124b3203],
4	from	IN	O	from	_	0	SENT_84	[p5l1149t3124r1358b3203],
5	ﬂash	JJ	O	ﬂash	amod	6	SENT_84	[p5l1383t3124r1901b3203],
6	—	NN	O	—	prep_from	3	SENT_84	[p5l1383t3124r1901b3203],
7	frozen	JJ	O	frozen	amod	8	SENT_84	[p5l1383t3124r1901b3203],
8	specimens	NNS	O	specimen	_	0	SENT_84	[p5l1928t3150r2147b3225, p5l10t3253r267b3331],
9	of	IN	O	of	_	0	SENT_84	[p5l315t3252r415b3331],
10	carcinoid	NN	O	carcinoid	nn	14	SENT_84	[p5l442t3252r837b3331],
11	and	CC	O	and	_	0	SENT_84	[p5l880t3252r1037b3331],
12	pancreatic	JJ	O	pancreatic	conj_and	10	SENT_84	[p5l1079t3253r1519b3353],
13	endocrine	JJ	O	endocrine	amod	14	SENT_84	[p5l1564t3252r1987b3331],
14	tumors	NNS	O	tumor	prep_of	8	SENT_84	[p5l2032t3269r2147b3331, p5l11t3406r254b3476],
15	;	:	O	;	_	0	SENT_84	[p5l2032t3269r2147b3331, p5l11t3406r254b3476],
16	EGFR	NN	ORGANIZATION	egfr	conj_and	8	SENT_84	[p5l281t3387r496b3460],
17	exons	NNS	O	exon	nsubjpass	25	SENT_84	[p5l514t3406r756b3459],
18	18	CD	NUMBER	18	num	17	SENT_84	[p5l786t3386r908b3476],
19	,	,	O	,	_	0	SENT_84	[p5l786t3386r908b3476],
20	19	CD	NUMBER	19	num	17	SENT_84	[p5l942t3386r1064b3476],
21	,	,	O	,	_	0	SENT_84	[p5l942t3386r1064b3476],
22	and	CC	NUMBER	and	_	0	SENT_84	[p5l1094t3380r1250b3459],
23	21	CD	NUMBER	21	nsubjpass	25	SENT_84	[p5l1274t3386r1376b3458],
24	were	VBD	O	be	auxpass	25	SENT_84	[p5l1396t3406r1599b3459],
25	ampliﬁed	VBN	O	ampliﬁed	rcmod	16	SENT_84	[p5l1623t3380r2030b3481],
26	by	IN	O	by	_	0	SENT_84	[p5l2055t3380r2153b3481],
27	the	DT	O	the	det	30	SENT_84	[p5l11t3508r143b3587],
28	polymerase	NN	O	polymerase	nn	30	SENT_84	[p5l185t3508r682b3609],
29	chain	NN	O	chain	nn	30	SENT_84	[p5l726t3508r962b3587],
30	reaction	NN	O	reaction	agent	25	SENT_84	[p5l1004t3509r1356b3587],
31	with	IN	O	with	_	0	SENT_84	[p5l1395t3508r1588b3587],
32	primers	NNS	O	primer	prep_with	25	SENT_84	[p5l1630t3509r1968b3609],
33	described	VBN	O	describe	partmod	32	SENT_84	[p5l2014t3508r2145b3587, p5l12t3636r324b3715],
34	by	IN	O	by	_	0	SENT_84	[p5l361t3636r459b3737],
35	Lynch	NNP	PERSON	Lynch	agent	33	SENT_84	[p5l490t3636r748b3737],
36	et	FW	O	et	nn	37	SENT_84	[p5l785t3653r863b3715],
37	al.	FW	O	al.	tmod	33	SENT_84	[p5l893t3636r1064b3732],
38	1	CD	NUMBER	1	dep	37	SENT_84	[p5l893t3636r1064b3732],
39	;	:	O	;	_	0	SENT_84	[p5l893t3636r1064b3732],
40	and	CC	O	and	_	0	SENT_84	[p5l1103t3636r1262b3715],
41	amplicons	NNS	O	amplicon	conj_and	8	SENT_84	[p5l1297t3636r1748b3737],
42	Were	VBD	O	be	partmod	41	SENT_84	[p5l1783t3663r1988b3715],
43	se	FW	O	se	nn	44	SENT_84	[p5l2027t3663r2145b3715],
44	—	FW	O	—	advmod	42	SENT_84	[p5l2027t3663r2145b3715],

1	quenced	VBN	O	quence	_	0	SENT_85	[p6l11t20r375b121],
2	and	CC	O	and	_	0	SENT_85	[p6l420t20r576b99],
3	assessed	VBN	O	assess	conj_and	1	SENT_85	[p6l618t20r985b99],
4	for	IN	O	for	_	0	SENT_85	[p6l1026t20r1151b99],
5	predictive	JJ	O	predictive	amod	7	SENT_85	[p6l1189t20r1603b121],
6	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_85	[p6l1644t27r1857b100],
7	mutations	NNS	O	mutation	prep_for	1	SENT_85	[p6l1893t37r2146b99, p6l11t149r219b227],
8	(	VBP	O	(	dep	1	SENT_85	[p6l261t148r1028b249],
9	single-nucleotide	JJ	O	single-nucleotide	amod	10	SENT_85	[p6l261t148r1028b249],
10	substitutions	NNS	O	substitution	dobj	8	SENT_85	[p6l1064t148r1615b227],
11	in	IN	O	in	dep	18	SENT_85	[p6l1651t149r1733b226],
12	exons	NNS	O	exon	pobj	11	SENT_85	[p6l1767t174r2010b227],
13	18	CD	NUMBER	18	num	12	SENT_85	[p6l2050t154r2146b227],
14	and	CC	O	and	_	0	SENT_85	[p6l10t277r167b356],
15	21	CD	NUMBER	21	pobj	11	SENT_85	[p6l214t283r315b355],
16	and	CC	O	and	_	0	SENT_85	[p6l363t277r519b356],
17	in-frame	RB	O	in-frame	conj_and	11	SENT_85	[p6l565t277r934b356],
18	deletions	NNS	O	deletion	nsubj	3	SENT_85	[p6l982t277r1367b356],
19	in	IN	O	in	_	0	SENT_85	[p6l1415t278r1497b355],
20	exon	NN	O	exon	nn	22	SENT_85	[p6l1545t303r1746b356],
21	19	CD	NUMBER	19	num	22	SENT_85	[p6l1796t283r1953b369],
22	)	NN	O	)	prep_in	18	SENT_85	[p6l1796t283r1953b369],
23	.	.	O	.	_	0	SENT_85	[p6l1796t283r1953b369],

1	Research	NNP	O	Research	nn	2	SENT_86	[p6l2005t284r2147b361, p6l12t405r284b484],
2	authorization	NN	O	authorization	nsubjpass	4	SENT_86	[p6l310t405r885b484],
3	Was	VBD	O	be	auxpass	4	SENT_86	[p6l907t432r1069b484],
4	obtained	VBN	O	obtain	_	0	SENT_86	[p6l1098t405r1472b484],
5	from	IN	O	from	_	0	SENT_86	[p6l1499t405r1707b484],
6	all	DT	O	all	predet	8	SENT_86	[p6l1732t405r1832b484],
7	the	DT	O	the	det	8	SENT_86	[p6l1858t405r1988b484],
8	patients	NNS	O	patient	prep_from	4	SENT_86	[p6l2014t431r2147b506, p6l11t534r268b629],
9	,	,	O	,	_	0	SENT_86	[p6l2014t431r2147b506, p6l11t534r268b629],
10	and	CC	O	and	_	0	SENT_86	[p6l308t533r465b612],
11	the	DT	O	the	det	12	SENT_86	[p6l500t533r630b612],
12	study	NN	O	study	nsubjpass	14	SENT_86	[p6l668t533r894b634],
13	was	VBD	O	be	auxpass	14	SENT_86	[p6l921t560r1083b612],
14	approved	VBN	O	approve	conj_and	4	SENT_86	[p6l1120t533r1513b634],
15	by	IN	O	by	_	0	SENT_86	[p6l1549t533r1646b634],
16	the	DT	O	the	det	19	SENT_86	[p6l1678t533r1808b612],
17	institutional	JJ	O	institutional	amod	19	SENT_86	[p6l1843t534r2147b612, p6l11t661r254b740],
18	review	NN	O	review	nn	19	SENT_86	[p6l278t662r552b740],
19	board	NN	O	board	agent	14	SENT_86	[p6l574t661r843b740],
20	.	.	O	.	_	0	SENT_86	[p6l574t661r843b740],

1	N	NN	O	n	nn	3	SENT_87	[p6l138t797r214b868],
2	o	NN	O	o	nn	3	SENT_87	[p6l218t815r266b868],
3	mutations	NNS	O	mutation	nsubjpass	18	SENT_87	[p6l305t790r738b868],
4	in	IN	O	in	_	0	SENT_87	[p6l778t790r860b867],
5	the	DT	O	the	det	8	SENT_87	[p6l898t789r1028b868],
6	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_87	[p6l1064t796r1278b869],
7	kinase	NN	O	kinase	nn	8	SENT_87	[p6l1309t789r1582b869],
8	domain	NN	O	domain	prep_in	3	SENT_87	[p6l1621t789r1947b868],
9	that	WDT	O	that	nsubj	11	SENT_87	[p6l1985t789r2153b868],
10	were	VBD	O	be	cop	11	SENT_87	[p6l6t943r209b996],
11	predictive	JJ	O	predictive	rcmod	8	SENT_87	[p6l239t917r653b1018],
12	of	IN	O	of	_	0	SENT_87	[p6l685t917r786b996],
13	a	DT	O	a	det	14	SENT_87	[p6l798t944r843b996],
14	response	NN	O	response	prep_of	11	SENT_87	[p6l872t943r1254b1018],
15	to	TO	O	to	_	0	SENT_87	[p6l1286t934r1365b996],
16	geﬁtinib	NN	O	geﬁtinib	prep_to	14	SENT_87	[p6l1397t917r1754b1018],
17	Were	VBD	O	be	auxpass	18	SENT_87	[p6l1782t944r1985b996],
18	detected	VBN	O	detect	_	0	SENT_87	[p6l2018t917r2147b996, p6l11t1045r262b1124],
19	in	IN	O	in	_	0	SENT_87	[p6l302t1046r384b1123],
20	DNA	NN	MISC	dna	prep_in	18	SENT_87	[p6l423t1052r636b1124],
21	from	IN	O	from	_	0	SENT_87	[p6l673t1045r882b1124],
22	62	CD	NUMBER	62	num	25	SENT_87	[p6l924t1051r1024b1124],
23	human	JJ	O	human	amod	25	SENT_87	[p6l1065t1045r1367b1124],
24	carcinoid	NN	O	carcinoid	nn	25	SENT_87	[p6l1408t1045r1802b1124],
25	tumors	NNS	O	tumor	prep_from	18	SENT_87	[p6l1843t1062r2146b1124],
26	from	IN	O	from	_	0	SENT_87	[p6l11t1173r219b1252],
27	a	DT	O	a	det	28	SENT_87	[p6l254t1200r298b1252],
28	variety	NN	O	variety	prep_from	25	SENT_87	[p6l326t1174r607b1274],
29	of	IN	O	of	_	0	SENT_87	[p6l638t1173r739b1252],
30	sites	NNS	O	site	prep_of	28	SENT_87	[p6l757t1174r967b1269],
31	,	,	O	,	_	0	SENT_87	[p6l757t1174r967b1269],
32	including	VBG	O	include	_	0	SENT_87	[p6l1007t1173r1416b1274],
33	both	DT	O	both	det	35	SENT_87	[p6l1448t1173r1642b1252],
34	primary	JJ	O	primary	amod	35	SENT_87	[p6l1675t1174r2014b1274],
35	lesions	NNS	O	lesion	nsubj	36	SENT_87	[p6l2043t1173r2147b1252, p6l12t1303r236b1381],
36	(	VBP	O	(	prep_including	18	SENT_87	[p6l279t1307r411b1394],
37	22	CD	NUMBER	22	dobj	36	SENT_87	[p6l279t1307r411b1394],
38	from	IN	O	from	_	0	SENT_87	[p6l448t1301r660b1381],
39	the	DT	O	the	det	40	SENT_87	[p6l696t1302r828b1381],
40	lung	NN	O	lung	prep_from	37	SENT_87	[p6l863t1302r1082b1404],
41	,	,	O	,	_	0	SENT_87	[p6l863t1302r1082b1404],
42	28	CD	NUMBER	28	dobj	36	SENT_87	[p6l1124t1307r1225b1381],
43	from	IN	O	from	_	0	SENT_87	[p6l1262t1301r1474b1381],
44	the	DT	O	the	det	45	SENT_87	[p6l1510t1302r1642b1381],
45	ileum	NN	O	ileum	prep_from	42	SENT_87	[p6l1678t1302r1948b1398],
46	,	,	O	,	_	0	SENT_87	[p6l1678t1302r1948b1398],
47	and	CC	O	and	_	0	SENT_87	[p6l1988t1302r2148b1381],
48	1	CD	NUMBER	1	conj_and	37	SENT_87	[p6l14t1437r58b1509],
49	from	IN	O	from	_	0	SENT_87	[p6l97t1431r302b1510],
50	the	DT	O	the	det	52	SENT_87	[p6l337t1432r464b1510],
51	colon	NN	O	colon	nn	52	SENT_87	[p6l499t1432r758b1523],
52	)	NN	O	)	prep_from	48	SENT_87	[p6l499t1432r758b1523],
53	and	CC	O	and	_	0	SENT_87	[p6l797t1432r951b1510],
54	metastatic	JJ	O	metastatic	amod	55	SENT_87	[p6l986t1433r1417b1510],
55	lesions	NNS	O	lesion	nsubj	56	SENT_87	[p6l1449t1432r1739b1510],
56	(	VBP	O	(	conj_and	36	SENT_87	[p6l1780t1437r1909b1523],
57	30	CD	NUMBER	30	dobj	56	SENT_87	[p6l1780t1437r1909b1523],
58	from	IN	O	from	_	0	SENT_87	[p6l1944t1431r2149b1510],
59	the	DT	O	the	det	60	SENT_87	[p6l11t1560r139b1638],
60	liver	NN	O	liver	prep_from	56	SENT_87	[p6l167t1560r347b1639],
61	and	CC	O	and	_	0	SENT_87	[p6l375t1560r532b1638],
62	1	CD	NUMBER	1	prep_including	18	SENT_87	[p6l567t1565r611b1637],
63	from	IN	O	from	_	0	SENT_87	[p6l643t1559r851b1638],
64	the	DT	O	the	det	66	SENT_87	[p6l883t1560r1013b1638],
65	ovary	JJ	O	ovary	amod	66	SENT_87	[p6l1046t1567r1324b1660],
66	)	NN	O	)	prep_from	62	SENT_87	[p6l1046t1567r1324b1660],
67	.	.	O	.	_	0	SENT_87	[p6l1046t1567r1324b1660],

1	Most	JJS	O	most	amod	3	SENT_88	[p6l1358t1567r1579b1638],
2	carcinoid	JJ	O	carcinoid	amod	3	SENT_88	[p6l1606t1560r2000b1638],
3	tumors	NNS	O	tumor	nsubj	8	SENT_88	[p6l2032t1576r2147b1639, p6l11t1714r227b1767],
4	in	IN	O	in	_	0	SENT_88	[p6l256t1690r337b1766],
5	this	DT	O	this	det	6	SENT_88	[p6l365t1689r519b1767],
6	study	NN	O	study	prep_in	3	SENT_88	[p6l550t1689r776b1789],
7	were	VBD	O	be	cop	8	SENT_88	[p6l795t1715r998b1768],
8	indolent	JJ	O	indolent	_	0	SENT_88	[p6l1024t1689r1405b1784],
9	;	:	O	;	_	0	SENT_88	[p6l1024t1689r1405b1784],
10	20	CD	NUMBER	20	num	12	SENT_88	[p6l1436t1694r1537b1767],
11	matched	VBN	O	match	amod	12	SENT_88	[p6l1565t1689r1932b1767],
12	sets	NNS	O	set	nsubjpass	31	SENT_88	[p6l1961t1705r2143b1785],
13	,	,	O	,	_	0	SENT_88	[p6l1961t1705r2143b1785],
14	which	WDT	O	which	nsubj	15	SENT_88	[p6l6t1818r268b1897],
15	included	VBD	O	include	rcmod	12	SENT_88	[p6l292t1818r653b1897],
16	an	DT	O	a	det	19	SENT_88	[p6l674t1844r774b1896],
17	ileal	JJ	O	ileal	amod	19	SENT_88	[p6l796t1818r965b1896],
18	primary	JJ	O	primary	amod	19	SENT_88	[p6l986t1819r1318b1918],
19	lesion	NN	O	lesion	dobj	15	SENT_88	[p6l1335t1818r1585b1896],
20	and	CC	O	and	_	0	SENT_88	[p6l1606t1818r1761b1896],
21	a	DT	O	a	det	24	SENT_88	[p6l1783t1844r1827b1896],
22	hepatic	JJ	O	hepatic	amod	24	SENT_88	[p6l1848t1818r2150b1918],
23	metastatic	JJ	O	metastatic	amod	24	SENT_88	[p6l11t1947r442b2024],
24	lesion	NN	O	lesion	conj_and	19	SENT_88	[p6l474t1946r725b2024],
25	from	IN	O	from	_	0	SENT_88	[p6l762t1945r971b2024],
26	the	DT	O	the	det	28	SENT_88	[p6l1007t1946r1137b2024],
27	same	JJ	O	same	amod	28	SENT_88	[p6l1175t1972r1394b2024],
28	patient	NN	O	patient	prep_from	15	SENT_88	[p6l1429t1947r1748b2046],
29	,	,	O	,	_	0	SENT_88	[p6l1429t1947r1748b2046],
30	were	VBD	O	be	auxpass	31	SENT_88	[p6l1785t1972r1988b2025],
31	examined	VBN	O	examine	parataxis	8	SENT_88	[p6l2026t1972r2147b2024, p6l10t2075r352b2153],
32	.	.	O	.	_	0	SENT_88	[p6l2026t1972r2147b2024, p6l10t2075r352b2153],

1	As	IN	O	as	_	0	SENT_89	[p6l137t2210r241b2281],
2	a	DT	O	a	det	3	SENT_89	[p6l262t2229r306b2281],
3	veriﬁcation	NN	O	veriﬁcation	prep_as	49	SENT_89	[p6l320t2202r789b2282],
4	of	IN	O	of	_	0	SENT_89	[p6l809t2202r909b2281],
5	our	PRP$	O	we	poss	7	SENT_89	[p6l911t2228r1054b2282],
6	detection	NN	O	detection	nn	7	SENT_89	[p6l1071t2203r1454b2281],
7	procedure	NN	O	procedure	prep_of	3	SENT_89	[p6l1472t2203r1917b2303],
8	,	,	O	,	_	0	SENT_89	[p6l1472t2203r1917b2303],
9	DNA	NN	O	dna	nsubj	10	SENT_89	[p6l1941t2210r2152b2282],
10	controls	VBZ	O	control	parataxis	49	SENT_89	[p6l11t2331r355b2409],
11	encoding	VBG	O	encode	xcomp	10	SENT_89	[p6l399t2331r798b2432],
12	EGFR	NN	ORGANIZATION	egfr	nn	14	SENT_89	[p6l834t2337r1048b2410],
13	mutations	NNS	O	mutation	nn	14	SENT_89	[p6l1083t2332r1516b2410],
14	L858R	NN	O	l858r	dep	11	SENT_89	[p6l1558t2336r1845b2414],
15	Within	IN	O	within	dep	14	SENT_89	[p6l1872t2331r2148b2410],
16	exon	NN	O	exon	pobj	15	SENT_89	[p6l11t2485r212b2538],
17	21	CD	NUMBER	21	num	16	SENT_89	[p6l286t2465r411b2556],
18	,	,	O	,	_	0	SENT_89	[p6l286t2465r411b2556],
19	delE746-A750	NN	O	dele746-a750	pobj	15	SENT_89	[p6l492t2460r1090b2538],
20	within	IN	O	within	_	0	SENT_89	[p6l1161t2460r1437b2539],
21	exon	NN	O	exon	prep_within	19	SENT_89	[p6l1512t2485r1713b2538],
22	19	CD	NUMBER	19	num	21	SENT_89	[p6l1791t2465r1912b2556],
23	,	,	O	,	_	0	SENT_89	[p6l1791t2465r1912b2556],
24	and	CC	O	and	_	0	SENT_89	[p6l1992t2460r2148b2538],
25	delL747-P753insS	NN	O	dell747-p753inss	pobj	15	SENT_89	[p6l11t2588r777b2668],
26	within	IN	O	within	_	0	SENT_89	[p6l807t2588r1083b2668],
27	exon	NN	O	exon	nn	30	SENT_89	[p6l1114t2613r1315b2667],
28	19	CD	NUMBER	19	num	30	SENT_89	[p6l1349t2593r1447b2667],
29	(	NN	O	(	nn	30	SENT_89	[p6l1483t2587r1697b2690],
30	gifts	NNS	O	gift	prep_within	11	SENT_89	[p6l1483t2587r1697b2690],
31	from	IN	O	from	_	0	SENT_89	[p6l1731t2587r1939b2667],
32	Drs.	NNP	O	Drs.	nn	34	SENT_89	[p6l1968t2595r2143b2667],
33	Daphne	NNP	PERSON	Daphne	nn	34	SENT_89	[p6l9t2718r338b2818],
34	Bell	NNP	PERSON	Bell	prep_from	11	SENT_89	[p6l360t2718r518b2796],
35	and	CC	O	and	_	0	SENT_89	[p6l540t2718r694b2796],
36	Daniel	NNP	PERSON	Daniel	nn	37	SENT_89	[p6l716t2718r988b2796],
37	Haber	NNP	PERSON	Haber	conj_and	34	SENT_89	[p6l1009t2718r1284b2814],
38	,	,	O	,	_	0	SENT_89	[p6l1009t2718r1284b2814],
39	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	41	SENT_89	[p6l1309t2718r1917b2797],
40	General	NNP	ORGANIZATION	General	nn	41	SENT_89	[p6l1942t2723r2148b2796, p6l11t2847r162b2925],
41	Hospital	NNP	ORGANIZATION	Hospital	appos	34	SENT_89	[p6l196t2847r579b2947],
42	,	,	O	,	_	0	SENT_89	[p6l196t2847r579b2947],
43	Charlestown	NNP	LOCATION	Charlestown	appos	41	SENT_89	[p6l622t2847r1185b2943],
44	,	,	O	,	_	0	SENT_89	[p6l622t2847r1185b2943],
45	Mass.	NNP	LOCATION	Mass.	nn	46	SENT_89	[p6l1226t2853r1504b2938],
46	)	NNP	O	)	nsubjpass	49	SENT_89	[p6l1226t2853r1504b2938],
47	Were	VBD	O	be	auxpass	49	SENT_89	[p6l1543t2873r1746b2926],
48	correctly	RB	O	correctly	advmod	49	SENT_89	[p6l1785t2847r2153b2947],
49	identiﬁed	VBN	O	identiﬁed	_	0	SENT_89	[p6l10t2975r440b3054],
50	.	.	O	.	_	0	SENT_89	[p6l10t2975r440b3054],

1	We	PRP	O	we	nsubj	2	SENT_90	[p6l477t2983r611b3054],
2	noted	VBD	O	note	_	0	SENT_90	[p6l647t2976r889b3054],
3	in	IN	O	in	_	0	SENT_90	[p6l922t2977r1004b3053],
4	one	CD	NUMBER	one	num	6	SENT_90	[p6l1040t3001r1194b3054],
5	ileal	JJ	O	ileal	amod	6	SENT_90	[p6l1229t2976r1403b3054],
6	carcinoid	NN	O	carcinoid	prep_in	2	SENT_90	[p6l1438t2976r1832b3054],
7	the	DT	O	the	dep	2	SENT_90	[p6l1868t2976r1998b3054],
8	reported	VBN	O	report	amod	7	SENT_90	[p6l2033t3002r2145b3054, p6l9t3104r293b3204],

1	germ-line	NN	O	germ-line	nsubj	3	SENT_91	[p6l319t3104r743b3205],
2	synonymous	JJ	O	synonymous	amod	1	SENT_91	[p6l770t3129r1313b3204],
3	coding	VBG	O	code	_	0	SENT_91	[p6l1342t3104r1959b3205],
4	—	NN	O	—	nn	5	SENT_91	[p6l1342t3104r1959b3205],
5	region	NN	O	region	dobj	3	SENT_91	[p6l1342t3104r1959b3205],
6	single-nucleotide	JJ	O	single-nucleotide	amod	8	SENT_91	[p6l1987t3105r2145b3182, p6l10t3232r632b3333],
7	polymorphism	NN	O	polymorphism	nn	8	SENT_91	[p6l656t3232r1288b3332],
8	C/T	NN	O	c/t	dep	14	SENT_91	[p6l1312t3237r1465b3321],
9	in	IN	O	in	_	0	SENT_91	[p6l1486t3232r1568b3309],
10	EGFR	NN	ORGANIZATION	egfr	prep_in	8	SENT_91	[p6l1589t3238r1803b3311],
11	exon	NN	O	exon	dep	14	SENT_91	[p6l1822t3257r2022b3310],
12	21	CD	NUMBER	21	num	11	SENT_91	[p6l2046t3237r2147b3309],
13	(	CD	NUMBER	(	num	14	SENT_91	[p6l15t3361r747b3456],
14	dbSNP	NN	O	dbsnp	dep	25	SENT_91	[p6l15t3361r747b3456],
15	:2229066	CD	NUMBER	:2229066	dep	14	SENT_91	[p6l15t3361r747b3456],
16	;	:	O	;	_	0	SENT_91	[p6l15t3361r747b3456],
17	nucleotide	NN	O	nucleotide	nn	18	SENT_91	[p6l777t3361r1211b3440],
18	position	NN	O	position	dep	14	SENT_91	[p6l1236t3362r1580b3461],
19	2694	CD	DATE	2694	dep	18	SENT_91	[p6l1605t3366r1811b3439],
20	in	IN	O	in	_	0	SENT_91	[p6l1836t3361r1917b3438],
21	GenBank	NN	LOCATION	genbank	nn	23	SENT_91	[p6l1942t3366r2148b3439, p6l9t3490r228b3570],
22	accession	NN	O	accession	nn	23	SENT_91	[p6l262t3491r661b3568],
23	number	NN	O	number	prep_in	14	SENT_91	[p6l700t3490r1038b3569],
24	X00588	CD	NUMBER	x00588	num	25	SENT_91	[p6l1074t3495r1460b3585],
25	)	NN	O	)	dep	3	SENT_91	[p6l1074t3495r1460b3585],
26	;	:	O	;	_	0	SENT_91	[p6l1074t3495r1460b3585],
27	it	PRP	O	it	nsubjpass	30	SENT_91	[p6l1505t3491r1565b3568],
28	Was	VBD	O	be	auxpass	30	SENT_91	[p6l1599t3516r1761b3570],
29	also	RB	O	also	advmod	30	SENT_91	[p6l1805t3490r1973b3568],
30	detected	VBN	O	detect	parataxis	3	SENT_91	[p6l2017t3490r2147b3568, p6l11t3618r262b3696],
31	in	IN	O	in	_	0	SENT_91	[p6l293t3619r374b3695],
32	normal	JJ	O	normal	amod	34	SENT_91	[p6l405t3618r714b3696],
33	surrounding	JJ	O	surrounding	amod	34	SENT_91	[p6l746t3618r1281b3719],
34	tissue	NN	O	tissue	prep_in	30	SENT_91	[p6l1309t3619r1576b3697],
35	.	.	O	.	_	0	SENT_91	[p6l1309t3619r1576b3697],

1	Similarly	RB	O	similarly	advmod	15	SENT_92	[p6l1614t3618r2004b3718],
2	,	,	O	,	_	0	SENT_92	[p6l1614t3618r2004b3718],
3	no	DT	O	no	det	4	SENT_92	[p6l2040t3643r2147b3696],
4	mutations	NNS	O	mutation	nsubjpass	15	SENT_92	[p7l11t22r444b100],
5	in	IN	O	in	_	0	SENT_92	[p7l468t22r549b98],
6	EGFR	NN	ORGANIZATION	egfr	prep_in	4	SENT_92	[p7l569t28r784b100],
7	exons	NNS	O	exon	nsubjpass	15	SENT_92	[p7l800t47r1042b99],
8	18	CD	NUMBER	18	num	7	SENT_92	[p7l1070t26r1192b117],
9	,	,	O	,	_	0	SENT_92	[p7l1070t26r1192b117],
10	19	CD	NUMBER	19	num	7	SENT_92	[p7l1223t26r1345b117],
11	,	,	O	,	_	0	SENT_92	[p7l1223t26r1345b117],
12	and	CC	NUMBER	and	_	0	SENT_92	[p7l1372t21r1529b99],
13	21	CD	NUMBER	21	conj_and	7	SENT_92	[p7l1551t26r1652b98],
14	were	VBD	O	be	auxpass	15	SENT_92	[p7l1670t47r1873b100],
15	found	VBN	O	find	_	0	SENT_92	[p7l1896t20r2148b100],
16	in	IN	O	in	_	0	SENT_92	[p7l10t150r92b226],
17	DNA	NN	O	dna	prep_in	15	SENT_92	[p7l116t156r330b228],
18	from	IN	O	from	_	0	SENT_92	[p7l353t148r562b227],
19	18	CD	NUMBER	18	num	23	SENT_92	[p7l590t154r687b227],
20	primary	JJ	O	primary	amod	23	SENT_92	[p7l714t150r1052b249],
21	pancreatic	JJ	O	pancreatic	amod	23	SENT_92	[p7l1073t150r1512b249],
22	endocrine	JJ	O	endocrine	amod	23	SENT_92	[p7l1539t149r1962b227],
23	carcinomas	NNS	O	carcinoma	prep_from	15	SENT_92	[p7l1989t175r2147b227, p7l11t279r394b356],
24	.	.	O	.	_	0	SENT_92	[p7l1989t175r2147b227, p7l11t279r394b356],

1	In	IN	O	in	dep	7	SENT_93	[p7l438t285r526b355],
2	contrast	NN	O	contrast	pobj	1	SENT_93	[p7l566t294r915b356],
3	to	TO	O	to	_	0	SENT_93	[p7l950t294r1029b356],
4	our	PRP$	O	we	poss	5	SENT_93	[p7l1072t303r1216b357],
5	results	NNS	O	result	prep_to	2	SENT_93	[p7l1253t278r1557b374],
6	,	,	O	,	_	0	SENT_93	[p7l1253t278r1557b374],
7	Lynch	NNP	PERSON	Lynch	_	0	SENT_93	[p7l1601t278r1856b378],
8	et	FW	O	et	nn	9	SENT_93	[p7l1896t294r1973b356],
9	al.	FW	O	al.	nsubj	11	SENT_93	[p7l2007t278r2148b356],
10	1	CD	NUMBER	1	dep	9	SENT_93	[p7l2007t278r2148b356],
11	found	VBD	O	find	rcmod	7	SENT_93	[p7l11t405r263b485],
12	no	DT	O	no	det	13	SENT_93	[p7l289t432r396b484],
13	mutations	NNS	O	mutation	dobj	11	SENT_93	[p7l424t407r858b485],
14	in	IN	O	in	_	0	SENT_93	[p7l886t407r967b483],
15	EGFR	NN	ORGANIZATION	egfr	nn	16	SENT_93	[p7l992t413r1206b485],
16	exons	NNS	O	exon	prep_in	11	SENT_93	[p7l1227t432r1469b484],
17	19	CD	NUMBER	19	npadvmod	11	SENT_93	[p7l1501t411r1599b484],
18	and	CC	O	and	_	0	SENT_93	[p7l1626t406r1783b484],
19	21	CD	NUMBER	21	conj_and	17	SENT_93	[p7l1810t411r1911b483],
20	in	IN	O	in	_	0	SENT_93	[p7l1937t407r2019b483],
21	40	CD	NUMBER	40	prep_in	11	SENT_93	[p7l2044t411r2147b484],

1	primary	JJ	O	primary	amod	3	SENT_94	[p7l9t536r341b635],
2	pancreatic	JJ	O	pancreatic	amod	3	SENT_94	[p7l360t536r790b635],
3	tumors	NNS	O	tumor	nsubj	4	SENT_94	[p7l814t551r1112b614],
4	(	VBP	O	(	_	0	SENT_94	[p7l1143t541r1286b626],
5	we	PRP	O	we	nsubj	8	SENT_94	[p7l1143t541r1286b626],
6	do	VBP	O	do	aux	8	SENT_94	[p7l1312t535r1413b613],
7	not	RB	O	not	neg	8	SENT_94	[p7l1440t551r1582b613],
8	know	VB	O	know	ccomp	4	SENT_94	[p7l1601t535r1837b614],
9	whether	IN	O	whether	complm	12	SENT_94	[p7l1853t535r2148b614, p7l11t689r92b741],
10	this	DT	O	this	det	11	SENT_94	[p7l115t663r265b741],
11	group	NN	O	group	nsubj	12	SENT_94	[p7l293t688r541b764],
12	included	VBD	O	include	ccomp	8	SENT_94	[p7l567t663r928b742],
13	rare	JJ	O	rare	amod	16	SENT_94	[p7l953t689r1113b741],
14	pancreatic	JJ	O	pancreatic	amod	16	SENT_94	[p7l1138t663r1568b763],
15	endocrine	JJ	O	endocrine	amod	16	SENT_94	[p7l1594t663r2009b741],
16	tumors	NNS	O	tumor	dobj	12	SENT_94	[p7l2036t679r2148b742, p7l11t798r255b883],
17	)	NN	O	)	dep	16	SENT_94	[p7l2036t679r2148b742, p7l11t798r255b883],
18	and	CC	O	and	_	0	SENT_94	[p7l281t792r437b870],
19	one	CD	NUMBER	one	num	22	SENT_94	[p7l460t818r613b870],
20	bronchial	JJ	O	bronchial	amod	22	SENT_94	[p7l635t792r1477b870],
21	—	NN	O	—	nn	22	SENT_94	[p7l635t792r1477b870],
22	carcinoid	NN	O	carcinoid	dobj	12	SENT_94	[p7l635t792r1477b870],
23	tumor-cell	NN	O	tumor-cell	nn	24	SENT_94	[p7l1499t792r1943b871],
24	line	NN	O	line	dep	22	SENT_94	[p7l1962t792r2143b870],
25	.	.	O	.	_	0	SENT_94	[p7l1962t792r2143b870],

1	N	NN	O	n	nn	3	SENT_95	[p7l527t960r540b975],
2	ENGLJ	NN	O	englj	nn	3	SENT_95	[p7l556t959r640b981],
3	MED	NN	O	med	_	0	SENT_95	[p7l655t960r707b975],
4	353	CD	NUMBER	353	num	6	SENT_95	[p7l720t959r784b981],
5	;	:	O	;	_	0	SENT_95	[p7l720t959r784b981],
6	2	CD	NUMBER	2	dep	3	SENT_95	[p7l720t959r784b981],
7	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	8	SENT_95	[p7l818t959r1030b981],
8	JULY	NNP	DATE	JULY	dep	6	SENT_95	[p7l1063t960r1123b981],
9	14	CD	DATE	14	num	8	SENT_95	[p7l1136t959r1170b981],
10	,	,	DATE	,	_	0	SENT_95	[p7l1136t959r1170b981],
11	2005	CD	DATE	2005	num	8	SENT_95	[p7l1183t959r1246b981],
12	209	CD	NUMBER	209	dep	3	SENT_95	[p7l1959t958r2016b980],

1	The	DT	O	the	det	4	SENT_96	[p7l702t992r753b1016],
2	New	NNP	O	New	nn	4	SENT_96	[p7l762t993r824b1016],
3	England	NNP	O	England	nn	4	SENT_96	[p7l833t992r944b1023],
4	Journal	NNP	O	Journal	_	0	SENT_96	[p7l953t992r1050b1016],
5	of	IN	O	of	_	0	SENT_96	[p7l1060t992r1089b1016],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_96	[p7l1095t992r1220b1016],

1	Downloaded	VBN	O	download	_	0	SENT_97	[p7l144t1033r314b1056],
2	from	IN	O	from	_	0	SENT_97	[p7l323t1033r387b1056],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_97	[p7l396t1033r514b1063],
4	at	IN	O	at	_	0	SENT_97	[p7l524t1037r548b1056],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_97	[p7l556t1033r739b1056],
6	on	IN	O	on	_	0	SENT_97	[p7l748t1040r780b1056],
7	January	NNP	DATE	January	prep_on	1	SENT_97	[p7l789t1033r892b1063],
8	5	CD	DATE	5	num	7	SENT_97	[p7l902t1033r924b1061],
9	,	,	DATE	,	_	0	SENT_97	[p7l902t1033r924b1061],
10	2014	CD	DATE	2014	num	7	SENT_97	[p7l935t1033r1007b1056],
11	.	.	O	.	_	0	SENT_97	[p7l935t1033r1007b1056],

1	For	IN	O	for	_	0	SENT_98	[p7l1018t1033r1064b1056],
2	personal	JJ	O	personal	amod	3	SENT_98	[p7l1072t1033r1185b1063],
3	use	NN	O	use	pobj	1	SENT_98	[p7l1194t1040r1237b1056],
4	only	RB	O	only	advmod	3	SENT_98	[p7l1247t1033r1312b1063],
5	.	.	O	.	_	0	SENT_98	[p7l1247t1033r1312b1063],

1	No	DT	O	no	det	3	SENT_99	[p7l1322t1033r1362b1056],
2	other	JJ	O	other	amod	3	SENT_99	[p7l1372t1033r1440b1056],
3	uses	NNS	O	use	_	0	SENT_99	[p7l1449t1040r1504b1056],
4	without	IN	O	without	_	0	SENT_99	[p7l1515t1033r1616b1056],
5	permission	NN	O	permission	prep_without	3	SENT_99	[p7l1624t1033r1777b1063],
6	.	.	O	.	_	0	SENT_99	[p7l1624t1033r1777b1063],

1	Copyright	NN	O	copyright	_	0	SENT_100	[p7l494t1074r629b1105],
2	©	CD	NUMBER	©	num	6	SENT_100	[p7l638t1074r661b1098],
3	2005	CD	DATE	2005	num	6	SENT_100	[p7l672t1074r736b1098],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_100	[p7l746t1074r937b1098],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_100	[p7l947t1074r1055b1098],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_100	[p7l1065t1074r1170b1105],
7	.	.	O	.	_	0	SENT_100	[p7l1065t1074r1170b1105],

1	All	DT	O	all	det	2	SENT_101	[p7l1181t1074r1223b1098],
2	rights	NNS	O	rights	nsubj	3	SENT_101	[p7l1232t1074r1307b1105],
3	reserved	VBN	O	reserve	_	0	SENT_101	[p7l1316t1074r1435b1098],
4	.	.	O	.	_	0	SENT_101	[p7l1316t1074r1435b1098],

